AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Please staple your payment here
請將股款
緊釘在此
This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019(the "Prospectus").
本申請表格使用上海復宏漢霖生物技術股份有限公司(「本公司」)於二零一九年九月十二日刊發的招股章程(「招 股章程」)所界定的相同詞彙。
Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act.
本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根 據美國證券法登記或豁免登記,香港發售股份不得在美國提呈發售或出售。
This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any | |
版 | |
manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of | |
that jurisdiction. |
任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得發送或派發或轉載(不論 方式,亦不論全部或部分)本申請表格及招股章程。
Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies" section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.
招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件-送呈公司註冊處處長文 件」一節所述的其他文件均已根據香港法例第32 章《公司(清盤及雜項條文)條例》第342C 條規定送呈香港公司註 冊處處長辦理登記。香港交易及結算所有限公司、香港聯合交易所有限公司(「聯交所」)、香港中央結算有限公司 (「香港結算」)、香港證券及期貨事務監察委員會(「證監會」)及香港公司註冊處處長對此等文件的內容概不負責。
Shanghai H nlius Biot ch, Inc.
上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司
(A joint stock company incorporated in the P op 's R public of China with limited liability) | ||
(於中華人民共和國註冊成立的股份有限公司) | ||
Stock code | : | 2696樣 |
股份代號 : | 2696 | |
Maximum Offer Price | : | HK$57.80 per Offer Share, plus brokerage fee of |
1%, SFC transaction levy of 0.0027% and Stock | ||
Exchange trading fee of 0.005% (payable in full | ||
on application in Hong Kong dollars, subject to | ||
refund) | ||
最高發售價 : 每股發售股份57.80 港元,另加1% 經紀佣金、 | ||
0.0027% 證監會交易徵費及0.005% 聯交所交 | ||
易費(須於申請時以港元繳足,多繳款項可予退 | ||
還) | ||
Applic nts' decl r tion | 申請人聲明 | |
I/We agree to the terms nd conditions and application | 本人╱吾等同意本申請表格及招股章程的條款及 | |
procedures in this Application Form and the | 條件以及申請程序。請參閱本申請表格「丁. 填交 | |
Prospectus. Please refer to the "D. Effect of completing | 本申請表格的效用」一節。 | |
and submitting this Application Form" section of this | ||
Application Form. | ||
Warning:SampleOnly one application may be made for the 警告:任何人士僅可為本身利益以藍色申請表格 | ||
benefit of any person for Reserved Shares on a BLUE | 就預留股份作出一次申請。下列情況將不獲受 | |
Application Form. The following are liable to be | 理:就預留股份作出的重複或疑屬重複申請以及 | |
rejected: multiple or suspected multiple applications | 支票或銀行本票在首次過戶時未能兌現的申請。 | |
for Reserved Shares and applications where cheques or | ||
banker's cashier orders are dishonoured upon the first | ||
presentation. |
AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額) | |
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and | |
have difficulties applying online via www.eipo.com.hk | |
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格 | |
Name(s) and address of the Qualifying Fosun Pharma H Shareholder | User ID 使用者編號 |
合資格復星醫藥H 股股東姓名╱名稱及地址 |
Access Code 通行編號
CCS6535 | 版 | |||||||||||||||||||||||||||||||||||||||||||||
Apply for Assured Entitlement of Reserved Shares | Box A | |||||||||||||||||||||||||||||||||||||||||||||
Number of Fosun Pharma H Shares registered in your | ||||||||||||||||||||||||||||||||||||||||||||||
You may apply for a number of Reserved Shares pursuant to your Assured Entitlement that is equal to or less than the number stated | 甲欄 | name as at 4:30 p.m. on Wednesday, 4 September 2019 | ||||||||||||||||||||||||||||||||||||||||||||
in Box B. If you intend to apply for a number of Reserved Shares that is less than your Assured Entitlement, you MUST apply for a | (the "Record Date"): | |||||||||||||||||||||||||||||||||||||||||||||
number which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number | 於二零一九年九月四日(星期三)(「記錄日期」)下午四時 | |||||||||||||||||||||||||||||||||||||||||||||
of Assured Entitlement which is not one of the numbers set out in the table below, you MUST apply by using Blue Form eIPO | 三十分以 閣下名義登記之復星醫藥H 股數目: | |||||||||||||||||||||||||||||||||||||||||||||
only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the | ||||||||||||||||||||||||||||||||||||||||||||||
BLUE Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on | Box B | Number of Reserved Shares in your Assured Entitlement: | Amount payable if your Assured Entitlement is taken up | |||||||||||||||||||||||||||||||||||||||||||
application in respect of the excess Reserved Shares applied for or apply through the Blue Form eIPO service via www.eipo.com.hk. | 乙欄 | 閣下所獲保證配額之預留股份數目: | in full: | |||||||||||||||||||||||||||||||||||||||||||
You need to complete and sign this Application Form and submit one cheque (or banker's cashier order) for the exact amount of | 閣下保證配額獲全數接納應付款項: | |||||||||||||||||||||||||||||||||||||||||||||
remittance printed in Box B on the right or in the table below. | 樣 | HK$ 港元 | ||||||||||||||||||||||||||||||||||||||||||||
申請保證配額之預留股份 | ||||||||||||||||||||||||||||||||||||||||||||||
閣下申請保證配額之預留股份數目可相等於或少於乙欄列明的數目。倘 閣下擬申請的預留股份數目少於 閣下的保 | ||||||||||||||||||||||||||||||||||||||||||||||
證配額, 閣下必須申請下表中載列的其中一個數目(香港結算代理人除外)。倘 閣下擬申請不在下表中載列的其中 | ||||||||||||||||||||||||||||||||||||||||||||||
一個保證配額數目, 閣下必須用藍表eIPO 申請。倘 | 閣下擬申請保證配額以外的超額預留股份,則須填妥並簽署申 | |||||||||||||||||||||||||||||||||||||||||||||
請超額預留股份之藍色申請表格,並單獨匯款足額支付所申請超額預留股份的應付股款,或透過www.eipo.com.hk使 | ||||||||||||||||||||||||||||||||||||||||||||||
用藍表eIPO 服務遞交申請。 | ||||||||||||||||||||||||||||||||||||||||||||||
閣下須填妥及簽署本申請表格並提交一張支票(或銀行本票)支付於右方乙欄或下表列明的應付確切金額。 | ||||||||||||||||||||||||||||||||||||||||||||||
NUMBER OF RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS | ||||||||||||||||||||||||||||||||||||||||||||||
可供申請認購的預留股份數目及款項 | ||||||||||||||||||||||||||||||||||||||||||||||
Amount payable | Amount payable | Amount payable | Amount payable | |||||||||||||||||||||||||||||||||||||||||||
No. of Reserved | on application | No. of Reserved | on application | No. of Reserved | on application | No. of Reserved | on application | |||||||||||||||||||||||||||||||||||||||
Shares applied for | HK$ | Shares applied for | HK$ | Shares applied for | HK$ | Shares applied for | HK$ | |||||||||||||||||||||||||||||||||||||||
申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | |||||||||||||||||||||||||||||||||||||||
股份數目 | (港元) | 股份數目 | (港元) | 股份數目 | (港元) | 股份數目 | (港元) | |||||||||||||||||||||||||||||||||||||||
100 | 5,838.25 | 2,500 | 145,956.13 | 30,000 | 1,751,473.52 | 600,000 | 35,029,470.36 | |||||||||||||||||||||||||||||||||||||||
200 | 11,676.49 | 3,000 | 175,147.35 | 40,000 | 2,335,298.02 | 700,000 | 40,867,715.42 | |||||||||||||||||||||||||||||||||||||||
300 | 17,514.74 | 3,500 | 204,338.58 | 50,000 | 2,919,122.53 | 800,000 | 46,705,960.48 | |||||||||||||||||||||||||||||||||||||||
400 | 23,352.98 | 4,000 | 233,529.80 | 60,000 | 3,502,947.04 | 900,000 | 52,544,205.54 | |||||||||||||||||||||||||||||||||||||||
500 | 29,191.23 | 4,500 | 262,721.03 | 70,000 | 4,086,771.54 | 1,000,000 | 58,382,450.60 | |||||||||||||||||||||||||||||||||||||||
600 | 35,029.47 | 5,000 | 291,912.25 | 80,000 | 4,670,596.05 | 1,500,000 | 87,573,675.90 | |||||||||||||||||||||||||||||||||||||||
700 | 40,867.71 | 6,000 | 350,294.70 | 90,000 | 5,254,420.55 | 2,000,000 | 116,764,901.20 | |||||||||||||||||||||||||||||||||||||||
800 | 46,705.96 | 7,000 | 408,677.15 | 100,000 | 5,838,245.06 | 2,500,000 | 145,956,126.50 | |||||||||||||||||||||||||||||||||||||||
900 | 52,544.20 | 8,000 | 467,059.60 | 200,000 | 11,676,490.12 | 3,000,000 | 175,147,351.80 | |||||||||||||||||||||||||||||||||||||||
1,000 | 58,382.45 | 9,000 | 525,442.06 | 300,000 | 17,514,735.18 | 3,500,000 | 204,338,577.10 | |||||||||||||||||||||||||||||||||||||||
1,500 | 87,573.68 | 10,000 | 583,824.51 | 400,000 | 23,352,980.24 | 4,000,000 | 233,529,802.40 | |||||||||||||||||||||||||||||||||||||||
2,000 | 116,764.90 | 20,000 | 1,167,649.01 | 500,000 | 29,191,225.30 | 4,186,000 | 244,388,938.21 | |||||||||||||||||||||||||||||||||||||||
Write down the number of Reserved Shares you want to a ly for and the total amount | ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath. | |||||||||||||||||||||||||||||||||||||||||||||
請在以下適當空格內用墨水筆(以黑色為佳)填寫 | 閣下擬申請之預留股份數目及應繳總額,並在相應空格內加上「X」。 | |||||||||||||||||||||||||||||||||||||||||||||
Number of Assured Entitlement applied for | Total amount of remittance (HK$) | |||||||||||||||||||||||||||||||||||||||||||||
申請保證配額數目 | 付款總額(港元) | |||||||||||||||||||||||||||||||||||||||||||||
, | , | , | , | , | . | |||||||||||||||||||||||||||||||||||||||||
, | ||||||||||||||||||||||||||||||||||||||||||||||
0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | . | 0 | 0 | |||||||||||||||
1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | . | 1 | 1 | |||||||||||||||
2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | . | 2 | 2 | |||||||||||||||
3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | . | 3 | 3 | |||||||||||||||
4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | . | 4 | 4 | |||||||||||||||
5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | . | 5 | 5 | |||||||||||||||
6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | . | 6 | 6 | |||||||||||||||
7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | . | 7 | 7 | |||||||||||||||
8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | . | 8 | 8 | |||||||||||||||
9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | . | 9 | 9 | |||||||||||||||
You must pay for the Reserved Shares applied for pursuant to your Assured Entitlement by a separate cheque or banker's cashier order. | ||||||||||||||||||||||||||||||||||||||||||||||
閣下必須以獨立開出的支票或銀行本票支付根據 | 閣下的保證配額所申請的預留股份。 |
* Cheque or banker's cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The | ||||||||||
applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order. | ||||||||||
* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出,並須註明抬頭人為「中國銀行Sample( 香港) 代理人有限公司-復宏漢霖生物技術優先發售」。申請人名稱╱聯名申請的排名首位申請人名稱須與在支票╱銀行本 | ||||||||||
票的預印名稱或由銀行授權人士在支票╱銀行本票背書的名稱相同。 | ||||||||||
Cheque/Banker's cashier order number* | Signed by (all) applicant(s) (all joint applicants must sign): | |||||||||
支票╱銀行本票號碼* | 由(所有)申請人簽署(所有聯名申請人必須簽署): | |||||||||
Name of bank on which cheque/banker's | ||||||||||
cashier order is drawn* | ||||||||||
支票╱銀行本票之付款銀行名稱* | ||||||||||
Contact telephone no. | ||||||||||
聯絡電話號碼 | ||||||||||
You (or if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/ | ||||||||||
passport number/Hong Kong business registration certificate number (Please delete as appropriate) | ||||||||||
閣下或(倘 閣下為聯名申請人)排名首位申請人必須提供香港身份證號碼╱護照號碼╱香港商業登記 | Date 日期: | |||||||||
號碼(請刪除不適用者) | ................................... /................................... /................................... | |||||||||
D 日 | M 月 | Y 年 |
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表(Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Please staple your payment here
請將股款
緊釘在此
This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019 (the "Prospectus").
本申請表格使用上海復宏漢霖生物技術股份有限公司(「本公司」)於二零一九年九月十二日刊發的招股章程(「招 股章程」)所界定的相同詞彙。
Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act.
本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根 據美國證券法登記或豁免登記,香港發售股份不得在美國提呈發售或出售。
This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in | |
版 | |
any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under | |
the law of that jurisdiction. |
任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得發送或派發或轉載(不論方 式,亦不論全部或部分)本申請表格及招股章程。
Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies" section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.
招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件-送呈公司註冊處處長文 件」一節所述的其他文件均已根據香港法例第32 章《公司(清盤及雜項條文)條例》第342C 條規定送呈香港公司註 冊處處長辦理登記。香港交易及結算所有限公司、香港聯合交易所有限公司(「聯交所」)、香港中央結算有限公司 (「香港結算」)、香港證券及期貨事務監察委員會(「證監會」)及香港公司註冊處處長對此等文件的內容概不負責。
Shanghai H nlius Biot ch, Inc.
上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司
(A joint stock company incorporated in the P | op 's R public of China with limited liability) | |
(於中華人民共和國註冊成立的股份有限公司) | ||
Stock code | : | 樣 |
2696 | ||
股份代號 : | 2696 | |
Maximum Offer Price | : | HK$57.80 per Offer Share, plus brokerage fee of |
1%, SFC transaction levy of 0.0027% and Stock | ||
Exchange trading fee of 0.005% (payable in full | ||
on application in Hong Kong dollars, subject to | ||
refund) | ||
最高發售價 : 每股發售股份57.80 港元,另加1% 經紀佣金、 | ||
0.0027% 證監會交易徵費及0.005% 聯交所交 | ||
易費(須於申請時以港元繳足,多繳款項可予退 | ||
還) | ||
Applic nts' decl r tion | 申請人聲明 | |
I/We agree to the terms nd conditions and application | 本人╱吾等同意本申請表格及招股章程的條款及 | |
procedures in this Application Form and the | 條件以及申請程序。請參閱本申請表格「丁. 填交 | |
Prospectus. Please refer to the "D. Effect of completing | 本申請表格的效用」一節。 | |
and submitting this Application Form" section of this | ||
Application Form. | ||
Sample | ||
Warning: Only one application may be made for the | 警告:任何人士僅可為本身利益以藍色申請表格 | |
benefit of any person for excess Reserved Shares on a | 就超額預留股份作出一次申請。下列情況將不獲 | |
BLUE Application Form. The following are liable to be | 受理:就超額預留股份作出的重複或疑屬重複申 | |
rejected: multiple or suspected multiple applications for | 請以及支票或銀行本票在首次過戶時未能兌現的 | |
excess Reserved Shares and applications where cheques | 申請。 | |
or banker's cashier orders are dishonoured upon the | ||
first presentation. |
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表(Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
User ID 使用者編號
Access Code 通行編號
CCS6535
Apply for Excess Reserved Shares
Other than your Assured Entitlement, you may apply for excess Reserved Shares. If you intend to apply for excess Reserved Shares, you MUST apply for a number of excess Reserved Shares which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number of excess Reserved Shares which is not one of the numbers set out in the table below, you MUST apply by using Blue Form eIPO only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the BLUE Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on application in respect of the excess Reserved Shares applied for or apply through the Blue Form eIPO service via www.eipo.com.hk.
You need to complete and sign this Application Form and submit one cheque (or banker' s cashier order) for the exact amount of remittance in the table below.
申請超額預留股份
除保證配額外, 閣下亦可申請超額預留股份。倘 閣下擬申請超額預留股份, 閣下必須申請下表中載列的其中一個 超額預留股份數目(香港結算代理人除外)。倘 閣下擬申請不在下表中載列的其中一個超額預留股份數目, 閣下必 須用藍表eIPO 申請。倘 閣下擬申請保證配額以外的超額預留股份,則須填妥並簽署申請超額預留股份之藍色申請 表格,並單獨匯款足額支付所申請超額預留股份的應付股款,或透過www.eipo.com.hk使用藍表eIPO 服務遞交申請。 閣下須填妥及簽署本申請表格並提交一張支票(或銀行本票)支付下表中載列的應付確切金額。
NUMBER OF EXCESS RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS | |||||||||||||||||||||||||||||||||||||||||||||||
可供申請認購的超額預留股份數目及款項 | |||||||||||||||||||||||||||||||||||||||||||||||
Amount payable | Amount payable | Amount payable | Amount payable | ||||||||||||||||||||||||||||||||||||||||||||
No. of Reserved | on application | No. of Reserved | on application | No. of Reserved | on application | 版 | |||||||||||||||||||||||||||||||||||||||||
No. of Reserved | on application | ||||||||||||||||||||||||||||||||||||||||||||||
Shares applied for | HK$ | Shares applied for | HK$ | Shares applied for | HK$ | Shares applied for | HK$ | ||||||||||||||||||||||||||||||||||||||||
申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | 申請認購的預留 | 申請時應繳款項 | ||||||||||||||||||||||||||||||||||||||||
股份數目 | (港元) | 股份數目 | (港元) | 股份數目 | (港元) | 股份數目 | (港元) | ||||||||||||||||||||||||||||||||||||||||
100 | 5,838.25 | 2,500 | 145,956.13 | 30,000 | 1,751,473.52 | 600,000 | 35,029,470.36 | ||||||||||||||||||||||||||||||||||||||||
200 | 11,676.49 | 3,000 | 175,147.35 | 40,000 | 2,335,298.02 | 700,000 | 40,867,715.42 | ||||||||||||||||||||||||||||||||||||||||
300 | 17,514.74 | 3,500 | 204,338.58 | 50,000 | 2,919,122.53 | 800,000 | 46,705,960.48 | ||||||||||||||||||||||||||||||||||||||||
400 | 23,352.98 | 4,000 | 233,529.80 | 60,000 | 3,502,947.04 | 900,000 | 52,544,205.54 | ||||||||||||||||||||||||||||||||||||||||
500 | 29,191.23 | 4,500 | 262,721.03 | 70,000 | 4,086,771.54 | 1,000,000 | 58,382,450.60 | ||||||||||||||||||||||||||||||||||||||||
600 | 35,029.47 | 5,000 | 291,912.25 | 80,000 | 4,670,596.05 | 1,500,000 | 87,573,675.90 | ||||||||||||||||||||||||||||||||||||||||
700 | 40,867.71 | 6,000 | 350,294.70 | 90,000 | 5,254,420.55 | 2,000,000 | 116,764,901.20 | ||||||||||||||||||||||||||||||||||||||||
800 | 46,705.96 | 7,000 | 408,677.15 | 100,000 | 5,838,245.06 | 2,500,000 | 145,956,126.50 | ||||||||||||||||||||||||||||||||||||||||
900 | 52,544.20 | 8,000 | 467,059.60 | 200,000 | 11,676,490.12 | 3,000,000 | 175,147,351.80 | ||||||||||||||||||||||||||||||||||||||||
1,000 | 58,382.45 | 9,000 | 525,442.06 | 樣 | 3,500,000 | 204,338,577.10 | |||||||||||||||||||||||||||||||||||||||||
300,000 | 17,514,735.18 | ||||||||||||||||||||||||||||||||||||||||||||||
1,500 | 87,573.68 | 10,000 | 583,824.51 | 400,000 | 23,352,980.24 | 4,000,000 | 233,529,802.40 | ||||||||||||||||||||||||||||||||||||||||
2,000 | 116,764.90 | 20,000 | 1,167,649.01 | 500,000 | 29,191,225.30 | 4,186,000 | 244,388,938.21 | ||||||||||||||||||||||||||||||||||||||||
Sample | |||||||||||||||||||||||||||||||||||||||||||||||
Write down the number of excess Reserved Shares you want to a ly for and the total amount ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath. | |||||||||||||||||||||||||||||||||||||||||||||||
請在以下適當空格內用墨水筆(以黑色為佳)填寫 | 閣下擬申請之超額預留股份數目及應繳總額,並在相應空格內加上「X」。 | ||||||||||||||||||||||||||||||||||||||||||||||
Number of excess Reserved Shares applied for | Total amount of remittance (HK$) | ||||||||||||||||||||||||||||||||||||||||||||||
申請超額預留股份數目 | 付款總額(港元) | ||||||||||||||||||||||||||||||||||||||||||||||
, | , | , | , | , | , | . | |||||||||||||||||||||||||||||||||||||||||
0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | , | 0 | 0 | 0 | . | 0 | 0 | ||||||||||||||||
1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | , | 1 | 1 | 1 | . | 1 | 1 | ||||||||||||||||
2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | , | 2 | 2 | 2 | . | 2 | 2 | ||||||||||||||||
3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | , | 3 | 3 | 3 | . | 3 | 3 | ||||||||||||||||
4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | , | 4 | 4 | 4 | . | 4 | 4 | ||||||||||||||||
5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | , | 5 | 5 | 5 | . | 5 | 5 | ||||||||||||||||
6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | , | 6 | 6 | 6 | . | 6 | 6 | ||||||||||||||||
7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | , | 7 | 7 | 7 | . | 7 | 7 | ||||||||||||||||
8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | , | 8 | 8 | 8 | . | 8 | 8 | ||||||||||||||||
9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | , | 9 | 9 | 9 | . | 9 | 9 | ||||||||||||||||
You must pay for the excess Reserved Shares applied for by a separate cheque or banker's cashier order. 閣下必須以獨立開出的支票或銀行本票支付所申請的超額預留股份。
* Cheque or banker' s cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order.
* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出,並須註明抬頭人為「中國銀行( 香港) 代理人有限公司-復宏漢霖生物技術優先發售」。申請人名稱╱聯名申請的排名首位申請人名稱須與在支票╱銀行本 | ||||
票的預印名稱或由銀行授權人士在支票╱銀行本票背書的名稱相同。 | ||||
Cheque/Banker's cashier order number* | Signed by (all) applicant(s) (all joint applicants must sign): | |||
支票╱銀行本票號碼* | 由(所有)申請人簽署(所有聯名申請人必須簽署): | |||
Name of bank on which cheque/banker's | ||||
cashier order is drawn* | ||||
支票╱銀行本票之付款銀行名稱* | ||||
Contact telephone no. | ||||
聯絡電話號碼 | ||||
You (or, if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/ | ||||
passport number/Hong Kong business registration certificate number (Please delete as appropriate) | ||||
閣下或(倘 閣下為聯名申請人)排名首位申請人必須提供香港身份證號碼╱護照號碼╱香港商業登記 | ||||
號碼(請刪除不適用者) | Date 日期: | ................................... /................................... /................................... |
D 日 | M 月 | Y 年 |
AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Application Form for Assured Entitlement of Qualifying Fosun Pharma H Shareholders
合 資 格 復 星 醫 藥 H 股 股 東 保 證 配 額 申 請 表 格
For Qualifying Fosun Pharma H Shareholders, | 合資格復星醫藥H 股股東的 | ||||||||
applications will be accepted until 12:00 noon | 截止接受申請時間 | ||||||||
on Tuesday, 17 September 2019. | 為二零一九年九月十七日 | ||||||||
You must read the conditions and instructions | (星期二)中午十二時正。 | ||||||||
attached to this Application Form. | 閣下務必細閱本申請表格隨附的 | ||||||||
To be valid, you must complete all applicable parts | 條件及指示。 | ||||||||
of this Application Form. | 本申請表格各適用部分必須以英文用墨水筆或 | ||||||||
Please write clearly in English and in ink. | 原子筆清楚填妥,方為有效。 | ||||||||
Mixed Media Offer | 混合媒介要約 | ||||||||
The Company will be relying on Section 9A of the Companies | 本公司將依據香港法例第32L 章《公司(豁免公司及招股 | ||||||||
(Exemption of Companies and Prospectuses from Compliance | 章程遵從條文)公告》第9A 條,在(i) 並非與招股章程印 | ||||||||
with Provisions) Notice (Chapter 32L of the Laws of Hong | 刷本一併發出的情況下,發出白色及黃色申請表格;及 | ||||||||
Kong) and will be issuing the (i) WHITE and YELLOW | (ii) 並非與招股章程印刷本一併發出的情況下,向相關 | ||||||||
Application Forms without them being accompanied by a | 合資格復星國際股東發出橙色申請表格及向相關合資格 | ||||||||
printed Prospectus; and (ii) the ORANGE Application Forms | 復星醫藥H 股股東發出藍色申請表格,除非相關合資格 | ||||||||
to the relevant Qualifying Fosun International Shareholders and | 復星國際股東或相關合資格復星醫藥H 股股東(視情況 | ||||||||
the BLUE Application Forms to the relevant Qualifying Fosun | 而定)已選擇根據復星國際或復星醫藥(視情況而定)公 | ||||||||
Pharma H Shareholders without them being accompanied by | 司通訊政策收取公司通訊印刷本或未被要求選擇收取復 | ||||||||
a printed Prospectus, unless the relevant Qualifying Fosun | 版 | ||||||||
星國際或復星醫藥(視情況而定)公司通訊稿的方式,在 | |||||||||
International Shareholders or the relevant Qualifying Fosun | 此情況下,招股章程印刷本會分開寄發予彼等。招股章 | ||||||||
Pharma H Shareholders (as the case may be) have el ct d to | 程的印刷本的內容與招股章程的電子版本相同,招股章 | ||||||||
receive corporate communications in printed form und r the | 程的電子版本分別在本公司網站www.henlius.com及聯 | ||||||||
corporate communications policy of Fosun International or | 交所網站www.hkexnews.hk「披露易>上市公司公告> | ||||||||
Fosun Pharma (as the case may be), or have not been ask d to | 最新上市公司公告」一欄中可供查閱及下載。 | ||||||||
elect the means of receiving the corporate communications of | 樣 | ||||||||
Fosun International or Fosun Pharma (as the case may b ), in | |||||||||
which case the printed Prospectus will be des atched to them | |||||||||
separately. The contents of the printed Pros ectus are identical | |||||||||
to the electronic version of the Pros ectus which can be | |||||||||
accessed and downloaded from the websites of the Com any at | |||||||||
www.henlius.comand the Stock Exchange at www.hkexnews. | |||||||||
hkunder the "HKExnews > Listed Com any Information > | |||||||||
Latest Listed Company Infor ation " section, respectively. | |||||||||
Members of the public, the Qualifying Fosun International | 有意索取招股章程印刷本的公眾人士、合資格復星國 | ||||||||
Shareholders and the Qualifying Fosun Phar a H Shareholders | 際股東及合資格復星醫藥H 股股東可於二零一九年九月 | ||||||||
who wish to obt in copy of the printed Prospectus | ay obtain | 十二日(星期四)上午九時正至二零一九年九月十七日 | |||||||
a copy, free of ch rge, upon request during nor | al business | (星期二)中午十二時正的正常辦公時間內,在以下地點 | |||||||
hours from 9:00 | . . on Thursd y, 12 Septe ber 2019 until | 免費索取: | |||||||
12:00 noon on Tuesd y, 17 September 2019 at the following | |||||||||
locations: | |||||||||
1. any of the following br nches of the receiving banks of the | 1. 本公司收款銀行的下列任何分行: | ||||||||
Company: | |||||||||
Bank of China (Hong Kong) Limited | 中國銀行(香港)有限公司 | ||||||||
District | Branch Name | Address | 地區 | 分行名稱 | 地址 | ||||
Hong Kong Island | Des Voeux Road | 111-119 Des Voeux Road West, | 香港島 | 德輔道西分行 | 香港德輔道西 | ||||
West Branch | Hong Kong | 111-119號 | |||||||
SampleChai Wan Branch Block B, Walton Estate, | 柴灣分行 | 香港 | |||||||
341-343 Chai Wan Road, | 柴灣道341-343號 | ||||||||
Chai Wan, | 宏德居B座 | ||||||||
Hong Kong | |||||||||
Kowloon | Telford Plaza Branch | Shop Unit P2-P7, | 九龍 | 德福廣場分行 | 九龍灣 | ||||
Telford Plaza, | 偉業街33號 | ||||||||
No.33 Wai Yip Street, | 德福廣場 | ||||||||
Kowloon Bay, | P2-P7號舖 | ||||||||
Kowloon | |||||||||
AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Olympian City Branch | Shop 133, 1/F, | 奧海城分行 | 九龍 | ||||
Olympian City 2, | 海庭道18號 | ||||||
18 Hoi Ting Road, | 奧海城二期 | ||||||
Kowloon | 一樓133號 | ||||||
New Territories | Metro City Branch | Shop 209, Level 2, | 新界 | 新都城分行 | 新界 | ||
Metro City Phase 1, | 將軍澳 | ||||||
Tseung Kwan O, | 新都城一期 | ||||||
版 | |||||||
New Territories | 二樓209號 | ||||||
Ma On Shan Plaza | Shop 2103, Level 2, | 馬鞍山廣場分行 | 新界 | ||||
Branch | Ma On Shan Plaza, | 馬鞍山 | |||||
Sai Sha Road, | 西沙路 | ||||||
Ma On Shan, | 馬鞍山廣場 | ||||||
New Territories | L2層2103號 | ||||||
CMB Wing Lung Bank Limited | 招商永隆銀行有限公司 | ||||||
樣 | 地址 | ||||||
District | Branch Name | Address | 地區 | 分行名稱 | |||
Hong Kong Island | Head Office | 45 Des Voeux Road Central | 香港島 | 總行 | 德輔道中45號 | ||
Kennedy Town Branch | 28 Catchick Street | 堅尼地城分行 | 吉席街28號 | ||||
Kowloon | Mongkok Branch | B/F CMB | 九龍 | 旺角分行 | 彌敦道636號 | ||
Wing Lung Bank Centre, | 招商永隆 | ||||||
636 Nathan Road | 銀行中心地庫 | ||||||
Tsim Sha Tsui Branch | 4 Carnarvon Road | 尖沙咀分行 | 加拿分道4號 | ||||
Sample | 新界 | 荃灣分行 | 沙咀道251號 | ||||
New Territories | Tsuen Wan Branch | 251 Sha Tsui Road | |||||
2. any of the following offices of | the below Joint G obal | 2. 以下聯席全球協調人的下列任何辦事處: | |||||
Coordinators: | |||||||
China International Capital Corporation Hong Kong | 中國國際金融香港證券有限公司 | ||||||
Securities Limited | 香港 | ||||||
29th Floor, One International Finance Centre | 中環 | ||||||
1 Harbour View Street | 港景街1 號 | ||||||
Central | 國際金融中心一期29 樓 | ||||||
Hong Kong | |||||||
Merrill Lynch (Asia Pacific) Limited | Merrill Lynch (Asia Pacific) Limited | ||||||
Level 55 Cheung Kong Center | 香港 | ||||||
2 Queen's Road Central | 中環 | ||||||
Central | 皇后大道中2 號 | ||||||
Hong Kong | 長江集團中心55 樓 | ||||||
BOCI Asia Li | ited | 中銀國際亞洲有限公司 | |||||
26th Floor, B nk of China Tower | 香港 | ||||||
1 G rden Ro d | 中環 | ||||||
Centr l | 花園道1 號 | ||||||
Hong Kong | 中銀大廈26 樓 | ||||||
UBS AG Hong Kong Br nch | UBS AG Hong Kong Branch | ||||||
52/F, Two International Finance Centre | 香港 | ||||||
8 Finance treet | 中環 | ||||||
Central | 金融街8 號 | ||||||
Hong Kong | 國際金融中心二期52 樓 | ||||||
CMB International Capital Limited | 招銀國際融資有限公司 | ||||||
45/F, Champion Tower | 香港 | ||||||
3 Garden Road | 中環 | ||||||
Central | 花園道3 號 | ||||||
Hong Kong | 冠君大廈45 樓 | ||||||
Fosun Hani Securities Limited | 復星恆利證券有限公司 | ||||||
Suite 2101-2105 21/F Champion Tower | 香港 | ||||||
3 Garden Road | 中環 | ||||||
Central | 花園道3 號 | ||||||
Hong Kong | 冠君大廈21 樓2101-2105室 | ||||||
AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
3. the Depository Counter of HKSCC at 1/F, One & Two Exchange | 3. 香港結算存管處服務櫃檯,地址為香港中環康樂廣 | |||||
Square, 8 Connaught Place, Central, Hong Kong. | 場8 號交易廣場一座及二座一樓。 | |||||
Details of where printed Prospectuses may be obtained | 可索取招股章程印刷本的地址詳情將於派發白色申請表 | |||||
will be displayed prominently at every designated branch | 格的收款銀行各指定分行以顯眼方式展示。 | |||||
of receiving banks where WHITE Application Forms are | ||||||
distributed. | ||||||
During normal business hours from 9:00 a.m. on Thursday, 12 | 於二零一九年九月十二日(星期四)上午九時正至二零 | |||||
版 | ||||||
September 2019 until 12:00 noon on Tuesday, 17 September | 一九年九月十七日(星期二)中午十二時正的正常辦公時 | |||||
2019, at least three copies of the printed Prospectus will be | 間內,在派發白色及黃色申請表格的各個地點(載於招 | |||||
available for inspection at every location where the WHITE | 股章程「如何申請香港發售股份及預留股份」),均有至 | |||||
and YELLOW Application Forms are distributed as set out in | 少三份招股章程印刷本可供查閱。 | |||||
the section headed "How to Apply for Hong Kong Offer Shares | ||||||
and Reserved Shares" in the Prospectus. | ||||||
To: Shanghai Henlius Biotech, Inc. | 致: 上海復宏漢霖生物技術股份有限公司 | |||||
樣 | ||||||
Joint Sponsors | 聯席保薦人 | |||||
Joint Global Coordinators | 聯席全球協調人 | |||||
Joint Representatives | 聯席代表 | |||||
Joint Bookrunners | 聯席賬簿管理人 | |||||
Hong Kong Underwriters | 香港包銷商 | |||||
Sample | ||||||
I/We: | 本人╱我們: | |||||
‧ being the Qualifying Fosun Pharma H Shareholder(s) nam d | ‧ 乃名列本申請表格之合資格復星醫藥H 股股東,按照招 | |||||
on this Application Form, apply for the number of R s rv d | 股章程及本申請表格所載條款及條件以及在 貴公司章 | |||||
Shares specified or deemed to be specified, on the t rms and | 程細則規限下,申請所指定或視作指定數目之預留股 | |||||
conditions of the Prospectus and this Application Form, and | 份; | |||||
subject to the Articles of Association of the Company; | ||||||
‧ enclose payment in full for the Reserved Shares app i d for | ‧ 隨附以最高發售價每股發售股份57.80 港元(多繳款項可 | |||||
at the Maximum Offer Price of HK$57.80 er Off r Share | 予退還)計算申請認購預留股份所需的全數付款(包括 | |||||
(subject to refund), including a 1% brokerage fee, a 0.0027% | 1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯交 | |||||
SFC transaction levy and a 0.005% Stock Exchange trading | 所交易費); | |||||
fee; | ||||||
‧ undertake and agree to accept the Reserved Shares a lied | ‧ 承諾及同意接納本人╱我們就本申請所申請認購的預留 | |||||
for, or any lesser number allotted to me/us on this a | lication; | 股份,或獲配發的任何較少數目; | ||||
‧ warrant that this is the | only a lication ade | by me/us | ‧ 保證是項申請乃本人╱我們就預留股份為本人╱我們本 | |||
for Reserved Shares for | y/our own benefit (other than an | 身利益作出之唯一申請(除以合資格復星國際股東身份 | ||||
application (if any) ade in the capacity as a Qualifying Fosun | 作出的申請(如有)外); | |||||
International Shareholder); | ||||||
‧ underst nd nd confirm th t these declarations and | ‧ 明白及確認 | 貴公司及聯席代表將依賴該等聲明及陳 | ||||
represent tions will be relied upon by the Co pany and the | 述,以決定是否就本申請向本人╱我們配發任何預留股 | |||||
Joint Represent tives in deciding whether or not to | ake any | 份,而本人╱我們如果作出虛假聲明可能會被檢椌; | ||||
allotment of Reserved Sh res to me/ us in response to this | ||||||
applic tion nd th t I/we m y be prosecuted for making a false | ||||||
declar tion; | ||||||
‧ authorise the Company to place my/our name(s) on the H | ‧ 授權 貴公司將本人╱我們的姓名╱名稱列入H 股股東 | |||||
hare register as the holder(s) of any Reserved Shares to be | 名冊內,作為將配發予本人╱我們的任何預留股份的持 | |||||
allotted to me/us and such other registers as required under | 有人,及根據 | 貴公司章程細則規定的其他登記冊內, | ||||
the Articles of Association of the Company, and despatch | 並按本申請表格上所示地址以普通郵遞方式向本人╱ | |||||
any hare certificate(s) (where applicable) and/or any refund | 我們寄發任何股票(如適用)及╱或任何退款支票(如適 | |||||
cheque(s) (where applicable) to me/us by ordinary post at my/ | 用),郵誤風險概由本人╱我們自行承擔(除非本人╱我 | |||||
our own risk to the address stated in this Application Form | 們申請1,000,000 股或以上預留股份,且本人╱我們符 | |||||
unless I/ we have applied for 1,000,000 Reserved Shares or | 合資格按本申請表格規定親自領取任何股票及╱或任何 | |||||
more and I/we am/are eligible to collect any Share certificate(s) | 退款支票(如適用)); |
and/or any refund cheque (where applicable) personally, as provided in this Application Form;
- undertake to sign all documents and to do all things necessary to enable me/us to be registered as the holder of the Reserved Shares to be allocated to me/us, and as required by the Articles of Association of the Company;
‧ 承諾簽署所有文件並採取所有必要的事宜,以及根 據 貴公司章程細則規定讓本人╱我們登記為本人╱我 們獲分配的預留股份的持有人;
AssuredEntitlement配額
保證
BLUE FORM 藍表(Assured Entitlement 保證配額)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
- request that any refund cheque(s) be made payable to me/ ‧ 要求任何退款支票以本人╱本申請表格內我們的排名首
the first-named of us (in the case of joint applicants) in this 位者(倘屬聯名申請人)為抬頭人; Application Form;
‧ have read the terms and conditions and application procedures | ‧ 已細閱本申請表格隨附各頁及招股章程所載的條款和條 | |
set out on the pages attached to this Application Form and in | 件及申請程序,並同意受其約束且知悉招股章程所述有 | |
the Prospectus and agree to be bound by them, and am aware | 關優先發售的限制; | |
of the restrictions on the Preferential Offering described in the | ||
Prospectus; | ||
‧ represent, warrant and undertake that the allotment of, or | ‧ 聲明、保證及承諾獲配發或申請認購預留股份不會引 | |
application for, the Reserved Shares would not require the | 致 貴公司、聯席保薦人、聯席全球協調人、聯席代 | |
Company, the Joint Sponsors, the Joint Global Coordinators, | 表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從 | |
the Joint Representatives the Joint Bookrunners, the Joint Lead | 香港以外任何地區的任何法律或法規的任何規定(不論 | |
Managers or the Underwriters to comply with any requirements | 是否具法律效力); | |
under any law or regulation (whether or not having the force of | ||
law) of any territory outside Hong Kong; | ||
‧ represent, warrant and undertake that I am not/ we are not | ‧ 聲明、保證及承諾本人╱我們並非香港或其他地區任何 | |
restricted by any applicable laws of Hong Kong or elsewhere | 適用法律規定不得作出是項申請、支付任何申請款項或 | |
from making this application, paying any application monies | 獲配發或接納任何預留股份的受限制人士;及本人╱我 | |
for, or being allotted or taking up any Reserved Shares; that I/ | 們明白預留股份並無亦不會根據美國證券法登記;本人 | |
we understand that the Reserved Shares have not been and will | ╱我們將在「離岸交易」(定義見美國證券法S 規例)中購 | |
not be registered under the U.S. Securities Act; and that I/we | 買預留股份;及 | 版 |
will acquire the Reserved Shares in an "offshore transaction" | ||
(within the meaning of Regulation S under the U.S. Securities | ||
Act); and | ||
‧ agree that this application, any acceptance of it and the | ‧ 同意本申請、任何對本申請的接納以及因此訂立的合 | |
resulting contract, will be governed by and constru d in | 約,將受香港法例規管及按其詮釋。 | |
accordance with the laws of Hong Kong. | ||
Warning: | 警告: | |
‧ It is important that you read the terms and conditions and | ‧ 閣下必須細閱招股章程及本申請表格所載的條款和條樣 | |
application procedures set out in the Pros ectus and in this | 件及申請程序。 | |
Application Form. | ||
‧ You must sign this application in writing (and not by way | ‧ 閣下必須以書面方式(不得以個人印章方式)簽署本申 | |
of personal chop), otherwise the a lication is liable to be | 請,否則申請會被拒絕受理。 | |
rejected. | ||
‧ Only one application ay be ade for the benefit of any | ‧ 任何人士僅可為本身利益以藍色申請表格就預留股份 | |
person for Reserved Shares on a BLUE Application Form. | 作出一次申請。下列情況將不獲受理:於藍色申請表 | |
The following are liable to be rejected: ultiple or suspected | 格或透過藍表eIPO 服務就預留股份作出的重複或疑屬 | |
multiple applications for Reserved Shares on the BLUE | 重複申請以及支票或銀行本票在首次過戶時未能兌現 | |
Applic tion Form or through Blue Form eIPO service and | 的申請。 | |
applic tions where cheques or b nker's cashier orders are | ||
dishonoured upon the first present tion. | ||
‧ You m y be prosecuted if you m ke a false declaration. | ‧ 倘 閣下作出虛假聲明,則可遭檢控。 | |
‧ All inform tion st ted in this Application Form must be | ‧ 在本申請表格中聲明的所有資料必須與復星醫藥或其 | |
the s me s th t m int ined by Fosun Pharma or any of its | 任何全資附屬公司所保存者相同。 | |
wholly-owned subsidiaries. | ||
‧ You must complete this application in English (except | ‧ 除中文姓名╱名稱外, 閣下必須以英文填妥本申請 | |
Chinese name) unless otherwise stated, otherwise the | (除非另有指明),否則申請會被拒絕受理。 | |
application is liable to be rejected. | ||
‧ Any alteration to any application detail that you provide on | ‧ 閣下於本申請表格提供的任何申請資料如有任何更 | |
this Application Form should be authorised by the signature | 改,須由申請人簽署授權。 | |
Sample | ||
of the applicant. |
- You or, if you are joint applicants, the first-named applicant must provide your Hong Kong identity card number/ passport number/Hong Kong business registration certificate number.
‧ 閣下或(倘 閣下為聯名申請人)排名首位申請人必須 提供香港身份證號碼╱護照號碼╱香港商業登記號碼。
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表 (Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Application Form for Excess Reserved Shares of Qualifying Fosun Pharma H Shareholders
合 資 格 復 星 醫 藥 H 股 股 東 超 額 預 留 股 份 申 請 表 格
For Qualifying Fosun Pharma H Shareholders, | 合資格復星醫藥H 股股東的 | ||||||
applications will be accepted until 12:00 noon | 截止接受申請時間 | ||||||
on Tuesday, 17 September 2019. | 為二零一九年九月十七日 | ||||||
You must read the conditions and instructions | (星期二)中午十二時正。 | ||||||
attached to this Application Form. | 閣下務必細閱本申請表格隨附的 | ||||||
To be valid, you must complete all applicable parts | 條件及指示。 | ||||||
of this Application Form. | 本申請表格各適用部分必須以英文用墨水筆或 | ||||||
Please write clearly in English and in ink. | 原子筆清楚填妥,方為有效。 | ||||||
Mixed Media Offer | 混合媒介要約 | ||||||
The Company will be relying on Section 9A of the Companies | 本公司將依據香港法例第32L 章《公司(豁免公司及招股 | ||||||
(Exemption of Companies and Prospectuses from Compliance | 章程遵從條文)公告》第9A 條,在(i) 並非與招股章程印 | ||||||
with Provisions) Notice (Chapter 32L of the Laws of Hong | 刷本一併發出的情況下,發出白色及黃色申請表格;及 | ||||||
Kong) and will be issuing the (i) WHITE and YELLOW | (ii) 並非與招股章程印刷本一併發出的情況下,向相關 | ||||||
Application Forms without them being accompanied by a | 合資格復星國際股東發出橙色申請表格及向相關合資格 | ||||||
printed Prospectus; and (ii) the ORANGE Application Forms | 復星醫藥H 股股東發出藍色申請表格,除非相關合資格 | ||||||
to the relevant Qualifying Fosun International Shareholders and | 復星國際股東或相關合資格復星醫藥H 股股東(視情況 | ||||||
the BLUE Application Forms to the relevant Qualifying Fosun | 而定)已選擇根據復星國際或復星醫藥(視情況而定)公 | ||||||
Pharma H Shareholders without them being accompanied by | 司通訊政策收取公司通訊印刷本或未被要求選擇收取復版 | ||||||
a printed Prospectus, unless the relevant Qualifying Fosun | 星國際或復星醫藥(視情況而定)公司通訊稿的方式,在 | ||||||
International Shareholders or the relevant Qualifying Fosun | 此情況下,招股章程印刷本會分開寄發予彼等。招股章 | ||||||
Pharma H Shareholders (as the case may be) have el ct d to | 程的印刷本的內容與招股章程的電子版本相同,招股章 | ||||||
receive corporate communications in printed form und r the | 程的電子版本分別在本公司網站www.henlius.com及聯 | ||||||
corporate communications policy of Fosun International or | 交所網站www.hkexnews.hk「披露易>上市公司公告> | ||||||
Fosun Pharma (as the case may be), or have not been ask d to | 最新上市公司公告」一欄中可供查閱及下載。 | ||||||
elect the means of receiving the corporate communications of | 樣 | ||||||
Fosun International or Fosun Pharma (as the case may b ), in | |||||||
which case the printed Prospectus will be des atched to them | |||||||
separately. The contents of the printed Pros ectus are identical | |||||||
to the electronic version of the Pros ectus which can be | |||||||
accessed and downloaded from the websites of the Com any at | |||||||
www.henlius.comand the Stock Exchange at www.hkexnews. | |||||||
hkunder the "HKExnews > Listed Com any Information > | |||||||
Latest Listed Company Infor ation " section, respectively. | |||||||
Members of the public, the Qualifying Fosun International | 有意索取招股章程印刷本的公眾人士、合資格復星國 | ||||||
Shareholders and the Qualifying Fosun Phar a H Shareholders | 際股東及合資格復星醫藥H 股股東可於二零一九年九月 | ||||||
who wish to obt in copy of the printed Prospectus | ay obtain | 十二日(星期四)上午九時正至二零一九年九月十七日 | |||||
a copy, free of ch rge, upon request during nor | al business | (星期二)中午十二時正的正常辦公時間內,在以下地點 | |||||
hours from 9:00 | . . on Thursd y, 12 Septe ber 2019 until | 免費索取: | |||||
12:00 noon on Tuesd y, 17 September 2019 at the following | |||||||
locations: | |||||||
1. any of the following br nches of the receiving banks of the | 1. 本公司收款銀行的下列任何分行: | ||||||
Comp ny: | |||||||
Bank of China (Hong Kong) Limited | 中國銀行(香港)有限公司 | ||||||
District | Branch Name | Address | 地區 | 分行名稱 | 地址 | ||
Hong Kong Island | Des Voeux Road | 111-119 Des Voeux Road West, | 香港島 | 德輔道西分行 | 香港德輔道西 | ||
West Branch | Hong Kong | 111-119號 | |||||
Chai Wan Branch | Block B, Walton Estate, | 柴灣分行 | 香港 | ||||
Sample341-343 Chai Wan Road, | 柴灣道341-343號 | ||||||
Chai Wan, | 宏德居B座 | ||||||
Hong Kong | |||||||
Kowloon | Telford Plaza Branch | Shop Unit P2-P7, | 九龍 | 德福廣場分行 | 九龍灣 | ||
Telford Plaza, | 偉業街33號 | ||||||
No.33 Wai Yip Street, | 德福廣場 | ||||||
Kowloon Bay, | P2-P7號舖 | ||||||
Kowloon | |||||||
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表 (Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Olympian City Branch | Shop 133, 1/F, | 奧海城分行 | 九龍 | ||||
Olympian City 2, | 海庭道18號 | ||||||
18 Hoi Ting Road, | 奧海城二期 | ||||||
Kowloon | 一樓133號 | ||||||
New Territories | Metro City Branch | Shop 209, Level 2, | 新界 | 新都城分行 | 新界 | ||
Metro City Phase 1, | 將軍澳 | ||||||
Tseung Kwan O, | 新都城一期 | ||||||
New Territories | 二樓209號 | ||||||
Ma On Shan Plaza | Shop 2103, Level 2, | 馬鞍山廣場分行 | 新界 | ||||
Branch | Ma On Shan Plaza, | 馬鞍山 | |||||
Sai Sha Road, | 西沙路 | ||||||
Ma On Shan, | 馬鞍山廣場 | ||||||
New Territories | L2層2103號 | ||||||
CMB Wing Lung Bank Limited | 招商永隆銀行有限公司 | ||||||
District | Branch Name | Address | 地區 | 分行名稱 | 地址 | ||
樣 | 德輔道中45號 | ||||||
Hong Kong Island | Head Office | 45 Des Voeux Road Central | 香港島 | 總行 | |||
Kennedy Town Branch | 28 Catchick Street | 堅尼地城分行 | 吉席街28號 | ||||
Kowloon | Mongkok Branch | B/F CMB | 九龍 | 旺角分行 | 彌敦道636號 | ||
Wing Lung Bank Centre, | 招商永隆 | ||||||
636 Nathan Road | 銀行中心地庫 | ||||||
Tsim Sha Tsui Branch | 4 Carnarvon Road | 新界 | 尖沙咀分行 版加拿分道4號 | ||||
New Territories | Tsuen Wan Branch | 251 Sha Tsui Road | 荃灣分行 | 沙咀道251號 | |||
Sample | |||||||
2. any of the following offices of | the below Joint Global | 2. | 以下聯席全球協調人的下列任何辦事處: | ||||
Coordinators: | |||||||
China International Capital Corporation Hong Kong | 中國國際金融香港證券有限公司 | ||||||
Securities Limited | 香港 | ||||||
29th Floor, One International Finance Centre | 中環 | ||||||
1 Harbour View Street | 港景街1 號 | ||||||
Central | 國際金融中心一期29 樓 | ||||||
Hong Kong | |||||||
Merrill Lynch (Asia Pacific) Limited | Merrill Lynch (Asia Pacific) Limited | ||||||
Level 55 Cheung Kong Center | 香港 | ||||||
2 Queen's Road Central | 中環 | ||||||
Central | 皇后大道中2 號 | ||||||
Hong Kong | 長江集團中心55 樓 | ||||||
BOCI Asia Li | ited | 中銀國際亞洲有限公司 | |||||
26th Floor, Bank of China Tower | 香港 | ||||||
1 G rden Ro d | 中環 | ||||||
Centr l | 花園道1 號 | ||||||
Hong Kong | 中銀大廈26 樓 | ||||||
UBS AG Hong Kong Br nch | UBS AG Hong Kong Branch | ||||||
52/F, Two Intern tion l Fin nce Centre | 香港 | ||||||
8 Fin nce treet | 中環 | ||||||
Centr l | 金融街8 號 | ||||||
Hong Kong | 國際金融中心二期52 樓 | ||||||
CMB International Capital Limited | 招銀國際融資有限公司 | ||||||
45/F, Champion Tower | 香港 | ||||||
3 Garden Road | 中環 | ||||||
Central | 花園道3 號 | ||||||
Hong Kong | 冠君大廈45 樓 | ||||||
Fosun Hani Securities Limited | 復星恆利證券有限公司 | ||||||
Suite 2101-2105 21/F Champion Tower | 香港 | ||||||
3 Garden Road | 中環 | ||||||
Central | 花園道3 號 | ||||||
Hong Kong | 冠君大廈21 樓2101-2105室 | ||||||
3. the Depository Counter of HKSCC at 1/F, One & Two Exchange | 3. | 香港結算存管處服務櫃檯,地址為香港中環康樂廣 | |||||
Square, 8 Connaught Place, Central, Hong Kong. | 場8 號交易廣場一座及二座一樓。 | ||||||
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表 (Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
可索取招股章程印刷本的地址詳情將於派發白色申請表 格的收款銀行各指定分行以顯眼方式展示。
During normal business hours from 9:00 a.m. on Thursday, 12 | 於二零一九年九月十二日(星期四)上午九時正至二零 | |||
September 2019 until 12:00 noon on Tuesday, 17 September, | 一九年九月十七日(星期二)中午十二時正的正常辦公時 | |||
2019, at least three copies of the printed Prospectus will be | 間內,在派發白色及黃色申請表格的各個地點(載於招 | |||
available for inspection at every location where the WHITE | 股章程「如何申請香港發售股份及預留股份」),均有至 | |||
and YELLOW Application Forms are distributed as set out in | 少三份招股章程印刷本可供查閱。 | |||
the section headed "How to Apply for Hong Kong Offer Shares | ||||
and Reserved Shares" in the Prospectus. | ||||
To: Shanghai Henlius Biotech, Inc. | 致: 上海復宏漢霖生物技術股份有限公司 | |||
Joint Sponsors | 聯席保薦人 | |||
Joint Global Coordinators | 聯席全球協調人 | |||
Joint Representatives | 聯席代表 | |||
Joint Bookrunners | 聯席賬簿管理人 | |||
Hong Kong Underwriters | 香港包銷商 | |||
I/We: | 本人╱我們: | |||
‧ being the Qualifying Fosun Pharma H Shareholder(s) named | ‧ 乃名列本申請表格之合資格復星醫藥H 股股東,按照招 | |||
on this Application Form, apply for the number of excess | 股章程及本申請表格所載條款及條件以及在 貴公司章 | |||
Reserved Shares specified or deemed to be specified, on the | 版 | |||
程細則規限下,申請所指定或視作指定數目之超額預留 | ||||
terms and conditions of the Prospectus and this Application | 股份; | |||
Form, and subject to the Articles of Association of the | ||||
Company; | ||||
‧ enclose payment in full for the excess Reserved Shar s app i d | ‧ 隨附以最高發售價每股發售股份57.80 港元(多繳款項可 | |||
for at the Maximum Offer Price of HK$57.80 per Off r Share | 予退還)計算申請認購超額預留股份所需的全數付款(包 | |||
(subject to refund), including a 1% brokerage fee, a 0.0027% | 括1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯 | |||
SFC transaction levy and a 0.005% Stock Exchange trading | 交所交易費); | |||
fee; | 樣 | |||
‧ undertake and agree to accept the excess Reserved Shares | ‧ 承諾及同意接納本人╱我們就本申請所申請認購的超額 | |||
applied for, or any lesser number allotted to me/us on this | 預留股份,或獲配發的任何較少數目; | |||
application; | ||||
‧ warrant that this is the only application made by me/us for | ‧ 保證是項申請乃本人╱我們就超額預留股份為本人╱我 | |||
excess Reserved Shares for y/our own benefit (other than an | 們本身利益作出之唯一申請(除以合資格復星國際股東 | |||
application (if any) ade in the capacity as a Qualifying Fosun | 身份作出的申請(如有)外); | |||
International Shareholder); | ||||
‧ underst nd nd confirm th t these declarations and | ‧ 明白及確認 貴公司及聯席代表將依賴該等聲明及陳 | |||
represent tions will be relied upon by the Co pany and the | 述,以決定是否就本申請向本人╱我們配發任何超額預 | |||
Joint Represent tives in deciding whether or not to ake any | 留股份,而本人╱我們如果作出虛假聲明可能會被檢 | |||
allotment of excess Reserved Sh res to me/ us in response to | 椌; | |||
this applic tion nd th t I/we m y be prosecuted for making a | ||||
false decl r tion; | ||||
‧ authorise the Comp ny to pl ce my/our name(s) on the H | ‧ 授權 貴公司將本人╱我們的姓名╱名稱列入H 股股東 | |||
hare register as the holder(s) of any excess Reserved Shares | 名冊內,作為將配發予本人╱我們的任何超額預留股份 | |||
to be allotted to me/us and such other registers as required | 的持有人,及根據 | 貴公司章程細則規定的其他登記冊 | ||
under the Articles of Association of the Company, and | 內,並按本申請表格上所示地址以普通郵遞方式向本人 | |||
despatch any hare certificate(s) (where applicable) and/or any | ╱我們寄發任何股票(如適用)及╱或任何退款支票(如 | |||
refund cheque(s) (where applicable) to me/us by ordinary post | 適用),郵誤風險概由本人╱我們自行承擔(除非本人╱ | |||
at my/ our own risk to the address stated in this Application | 我們申請1,000,000 股或以上超額預留股份,且本人╱ | |||
Sample | ||||
Form unless I/we have applied for 1,000,000 excess Reserved | 我們符合資格按本申請表格所述親自領取任何股票及╱ | |||
Shares or more and I/we am/are eligible to collect any Share | 或任何退款支票(如適用)); |
certificate(s) and/or any refund cheque (where applicable) personally, as provided in this Application Form;
- undertake to sign all documents and to do all things necessary to enable me/us to be registered as the holder of the excess Reserved Shares to be allocated to me/ us, and as required by the Articles of Association of the Company;
‧ 承諾簽署所有文件並採取所有必要的事宜,以及根 據 貴公司章程細則規定讓本人╱我們登記為本人╱我 們獲分配超額預留股份的持有人;
Excess | 請 |
Application | |
申 | |
額 | |
超 |
BLUE FORM 藍表 (Excess Application 超額申請)
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
- request that any refund cheque(s) be made payable to me/ ‧ 要求任何退款支票以本人╱本申請表格內我們的排名首
the first-named of us (in the case of joint applicants) in this 位者(倘屬聯名申請人)為抬頭人; Application Form;
‧ have read the terms and conditions and application procedures | ‧ 已細閱本申請表格隨附各頁及招股章程所載的條款和條 | |
set out on the pages attached to this Application Form and in | 件及申請程序,並同意受其約束且知悉招股章程所述有 | |
the Prospectus and agree to be bound by them, and am aware | 關優先發售的限制; | |
of the restrictions on the Preferential Offering described in the | ||
Prospectus; | ||
‧ represent, warrant and undertake that the allotment of, | ‧ 聲明、保證及承諾獲配發或申請認購超額預留股份不會 | |
or application for, the excess Reserved Shares would not | 引致 貴公司、聯席保薦人、聯席全球協調人、聯席代 | |
require the Company, the Joint Sponsors, the Joint Global | 表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從 | |
Coordinators, the Joint Representatives, the Joint Bookrunners, | 香港以外任何地區的任何法律或法規的任何規定(不論 | |
the Joint Lead Managers or the Underwriters to comply with | 是否具法律效力); | |
any requirements under any law or regulation (whether or not | ||
having the force of law) of any territory outside Hong Kong; | ||
‧ represent, warrant and undertake that I am not/we are not | ‧ 聲明、保證及承諾本人╱我們並非香港或其他地區任何 | |
restricted by any applicable laws of Hong Kong or elsewhere | 適用法律規定不得作出是項申請、支付任何申請款項或 | |
from making this application, paying any application monies | 獲配發或接納任何超額預留股份的受限制人士;及本人 | |
for, or being allotted or taking up any excess Reserved Shares; | ╱我們明白超額預留股份並無亦不會根據美國證券法登 | |
that I/we understand that the excess Reserved Shares have not | 記;本人╱我們將在「離岸交易」(定義見美國證券法S | |
been and will not be registered under the U.S. Securities Act; | 規例)中購買超額預留股份;及 | |
and that I/we will acquire the excess Reserved Shares in an | 版 | |
"offshore transaction" (within the meaning of Regulation S | ||
under the U.S. Securities Act); and | ||
‧ agree that this application, any acceptance of it and the | ‧ 同意本申請、任何對本申請的接納以及因此訂立的合 | |
resulting contract, will be governed by and constru d in | 約,將受香港法例規管及按其詮釋。 | |
accordance with the laws of Hong Kong. | 警告:樣 | |
Warning: | ||
‧ It is important that you read the terms and conditions and | ‧ 閣下必須細閱招股章程及本申請表格所載的條款和條 | |
application procedures set out in the Pros ectus and in this | 件及申請程序。 | |
Application Form. | ||
‧ You must sign this application in writing (and not by way | ‧ 閣下必須以書面方式(不得以個人印章方式)簽署本申 | |
of personal chop), otherwise the a lication is liable to be | 請,否則申請會被拒絕受理。 | |
rejected. | ||
‧ Only one application ay be ade for the benefit of any | ‧ 任何人士僅可為本身利益以藍色申請表格就超額預留 | |
person for excess Reserved Shares on a BLUE Application | 股份作出一次申請。下列情況將不獲受理:於藍色申 | |
Form. The following re li ble to be rejected: ultiple or | 請表格或透過藍表eIPO 服務就超額預留股份作出的重 | |
suspected multiple pplic tions for excess Reserved Shares | 複或疑屬重複申請以及支票或銀行本票在首次過戶時 | |
on the BLUE Applic tion Form or through Blue Form | 未能兌現的申請。 | |
eIPO service nd pplic tions where cheques or banker's | ||
cashier orders re dishonoured upon the first presentation. | ||
‧ You m y be prosecuted if you m ke a false declaration. | ‧ 倘 閣下作出虛假聲明,則可遭檢控。 | |
‧ All information stated in this Application Form must be | ‧ 在本申請表格中聲明的所有資料必須與復星醫藥或其 | |
the same as that maintained by Fosun Pharma or any of its | 任何全資附屬公司所保存者相同。 | |
wholly-owned subsidiaries. | ||
‧ You must complete this application in English (except | ‧ 除中文姓名╱名稱外, 閣下必須以英文填妥本申請 | |
Chinese name) unless otherwise stated, otherwise the | (除非另有指明),否則申請會被拒絕受理。 | |
application is liable to be rejected. | ||
‧SampleAny alteration to any application detail that you provide on ‧ 閣下於本申請表格提供的任何申請資料如有任何更 | ||
this Application Form should be authorised by the signature | 改,須由申請人簽署授權。 | |
of the applicant. | ||
‧ You or, if you are joint applicants, the first-named applicant | ‧ 閣下或(倘 閣下為聯名申請人)排名首位申請人必 | |
must provide your Hong Kong identity card number/ | 須提供香港身份證號碼╱護照號碼╱香港商業登記號 | |
passport number/Hong Kong business registration certificate | 碼。 |
number.
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
Shanghai Henlius Biotech, Inc.
上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司
(A joint stock company incorporated in the People's Republic of China with limited liability)
GLOBAL OFFERING | 版 | |||||||
Conditions of your Application | ||||||||
Notwithstanding any other provision in the Prospectus | ||||||||
Unless otherwise stated, terms used in these conditions have | or this Application Form or the terms and conditions of | |||||||
the same meanings ascribed thereto in the Prospectus. | the Blue Form eIPO service, the Company reserves | |||||||
A. Who can apply | the right to permit any Fosun Pharma H Shareholder to | |||||||
1. You, the applicant(s), and any person(s) for whose | take up his/her/its Assured Entitlement to the Reserved | |||||||
benefit you are applying, must be Qualifying Fosun | Shares if the Company, in its absolute discretion, is | |||||||
Pharma H Shareholder(s) and must be 18 years of age | satisfied that the transaction in question is exempt from | |||||||
樣 | ||||||||
or above. | or not subject to the legislation or regulations giving rise | |||||||
2. If you are a firm, the application must be in the names | to the restrictions described above. | |||||||
of the individual members, not in the name of the | 5. The number of joint applicants may not exceed four. | |||||||
firm. | B. Allocation of Reserved Shares | |||||||
3. If you are a body corporate, the application must | A valid application for a number of Reserved Shares that | |||||||
Sample | ||||||||
be stamped with the company chop (bearing the | is less than or equal to your Assured Entitlement will be | |||||||
company name) and signed by a duly authoris d | acc pt d in full, subject to the terms and conditions set out | |||||||
officer, who must state his or her repres ntative | in this Application Form and assuming that the conditions | |||||||
capacity. | of the Pr f r ntial Offering are satisfied. If an application | |||||||
4. Save under the circumstances permitted by the | is made for a number of Reserved Shares that is less than | |||||||
Listing Rules and guidance letters issued by the Stock | your Assur d Entitlement, you MUST apply for a number | |||||||
Exchange, or any | relevant waivers that | have b | n | in one of the numbers set out in the table of numbers and | ||||
granted by the Stock Exchange, you cannot a | y for | payments in this Application Form and make a payment of | ||||||
any Reserved Shares if you or (with the exce | tion of | the corresponding amount (other than HKSCC Nominees). | ||||||
HKSCC Nominees) any person(s) for whose benefit | If you intend to apply for a number of Assured Entitlement | |||||||
you are applying are/is: | which is not one of the numbers set out in the table in | |||||||
‧ an existing beneficial owner | of Shares | in | the | the BLUE Application Form for Assured Entitlement, | ||||
Company and/or any of its subsidiaries; | you MUST apply by using Blue Form eIPO only. If | |||||||
‧ a director or chief executive of the Co | pany and/ | you wish to apply for excess Reserved Shares in addition | ||||||
or any of the Co | pany's subsidiaries; | to your Assured Entitlement, you should complete and | ||||||
‧ n ssoci te of | ny of the bove persons; | sign the BLUE Application Form for excess Reserved | ||||||
Shares and lodge it, together with a separate remittance | ||||||||
‧ connected person of the Co | pany or a person | |||||||
for the full amount payable on application in respect of the | ||||||||
who will beco | e | connected person | of | the | ||||
excess Reserved Shares applied for or apply for through | ||||||||
Comp ny immedi tely upon completion of the | ||||||||
the Blue Form eIPO service via www.eipo.com.hk. If | ||||||||
Glob l Offering; or | ||||||||
an application is made for a number of Reserved Shares | ||||||||
‧ Non-Qu lifying Fosun Pharma H Shareholder. | ||||||||
that is greater than your Assured Entitlement, the relevant | ||||||||
Non-Qualifying Fosun Pharma H Shareholders are | application for Assured Entitlement will be satisfied in | |||||||
those Fosun Pharma H Shareholders with registered | full, but the application for excess Reserved Shares will | |||||||
addresses in, or who are otherwise known by Fosun | only be met to the extent that there are sufficient Available | |||||||
Pharma to be residents of, jurisdictions outside Hong | Reserved Shares. To the extent that excess applications for | |||||||
Kong on the Record Date, in respect of whom the | the Reserved Shares are: | |||||||
directors of Fosun Pharma and the Company, based | (i) less than the Available Reserved Shares, the Available | |||||||
on the enquiries made by them, consider it necessary | Reserved Shares will first be allocated to satisfy such | |||||||
or expedient to exclude from the Preferential Offering | excess applications for the Reserved Shares in full | |||||||
on account either of the legal restrictions under the | and thereafter will be allocated, at the discretion of the | |||||||
laws of the relevant jurisdiction in which the relevant | Joint Representatives, to the International Offering; | |||||||
Fosun Pharma H Shareholder is resident or the | (ii)equal to the Available Reserved Shares, the Available | |||||||
requirements of the relevant regulatory body or stock | Reserved Shares will be allocated to satisfy such | |||||||
exchange in that jurisdiction. | excess applications for the Reserved Shares in full; or | |||||||
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
(iii) more | than the Available Reserved Shares, the | applications will not be valid. Subject to the above, an | |||||||||
Available Reserved Shares will be allocated on an | application once made is irrevocable and applicants shall | ||||||||||
allocation basis which will be consistent with the | be deemed to have applied on the basis of the Prospectus | ||||||||||
allocation basis commonly used in the case of over- | as supplemented. | ||||||||||
subscriptions in public offerings in Hong Kong, where | D. Effect of completing and submitting this Application | ||||||||||
a higher allocation percentage will be | applied in | ||||||||||
Form | |||||||||||
respect of smaller applications. If there are any Shares | |||||||||||
By completing and submitting this Application Form, you | |||||||||||
left after satisfying | the excess applications, such | ||||||||||
(and if you are joint applicants, each of you jointly and | |||||||||||
Shares | will be re-allocated, at | the discretion of the | |||||||||
severally) for yourself or as an agent or a nominee and on | |||||||||||
Joint Representatives, to the International Offering. | |||||||||||
behalf of each person for whom you act as an agent or a | |||||||||||
No preference will be given to any excess applications | |||||||||||
nominee: | |||||||||||
made to top up odd lot holdings to whole lot holdings | |||||||||||
‧ instruct and authorise | the Company and/or Joint | ||||||||||
of Shares. | |||||||||||
Representatives | (or their respective agents | or | |||||||||
Save for | the above, the | Preferential Offering | will not | ||||||||
nominees), to execute any transfer forms, contract | |||||||||||
be subject to the clawback arrangement between the | 樣 | ||||||||||
International Offering | and the | Hong Kong | Public | notes or other documents on your behalf and to do | |||||||
Offering. Any application not accompanied by the correct | on | your behalf | all other things necessary to effect | ||||||||
amount of application monies will be treated as invalid | the registration of any Reserved Shares allocated to | ||||||||||
in its entirety and no Reserved Shares will be allotted to | you in your name(s) as required by the Articles of | ||||||||||
Association of the Company and otherwise to give | |||||||||||
such applicant. | effect to the arrangements版described in the Prospectus | ||||||||||
Sample | |||||||||||
In addition to any application for Reserved Shares made | and this Application Form; | ||||||||||
through the Blue Form eIPO services via | www. ipo. | ‧ und rtake to | sign | all | documents and to do | all | |||||
com.hkor on the BLUE Application Form, Qualifying | things n cessary | to | enable you to be | registered | as | ||||||
Fosun Pharma H Shareholders will be entit ed to make | the hold r of the Reserved Shares allocated to you, | ||||||||||
one application for Hong Kong Offer Shares on WHITE | and as r quired by the Articles of Association of the | ||||||||||
or YELLOW Application Forms or by giving e | ctronic | Company; | |||||||||
application instructions to HKSCC via CCASS or by | ‧ r pr s nt, warrant | and undertake that you | |||||||||
applying through the White Form eIPO service. | understand that the Reserved Shares have not been | ||||||||||
Qualifying Fosun Pharma H Shareholders wi | receive | and will not be registered under the U.S. Securities | |||||||||
no preference as to entitlement or allocation in res ect | Act; and that, | with the exception | of HKSCC | ||||||||
of applications for Hong Kong Offer Shares made on | Nominees, you | or | any other person for whose | ||||||||
WHITE or YELLOW Application Form or by giving | account or benefit you are acquiring Reserved Shares | ||||||||||
electronic application instructions to HKSCC or through | are | outside the | United | States | (within | the meaning | |||||
the White Form eIPO service under the Hong Kong | of | Regulation | S), and | are a | person | described | in | ||||
Public Offering. | paragraph (h)(3) of Rule 902 of Regulation S; | ||||||||||
Qualifying Fosun Ph r | H Shareholders | are | entitled | ||||||||
‧ confirm that you have only relied on the information | |||||||||||
to apply on the b sis of | n Assured Entitle | ent of one | |||||||||
and representations | contained | in the | Prospectus | in | |||||||
Reserved Sh re for every integr l | ultiple of 132 Fosun | ||||||||||
making this application, and will not rely on any other | |||||||||||
Pharma H | h res held by e ch Qualifying Fosun Pharma | ||||||||||
information or representation save as set out in any | |||||||||||
H h reholder on the Record Date. Qualifying Fosun | |||||||||||
supplement to the Prospectus; | |||||||||||
Pharma H h reholders who hold less than 132 Fosun | |||||||||||
‧ agree that none of the Company, | the Relevant | ||||||||||
Pharma H hares on the Record Date will not have an | |||||||||||
Persons or the Orange and Blue Form eIPO Service | |||||||||||
Assured Entitlement to the Reserved Shares, but they will | |||||||||||
Provider is or | will | be | liable | for any information | |||||||
still be entitled to participate in the Preferential Offering | |||||||||||
and representations | not | in the | Prospectus (and any | ||||||||
by applying for excess Reserved Shares. | |||||||||||
supplement to it); | |||||||||||
C. Supplemental information | ‧ agree (without prejudice to any other rights which | ||||||||||
If any supplement to the Prospectus is issued, applicant(s) | you may have) that once this application has been | ||||||||||
who have already submitted an application may or may | accepted, you may not rescind it due to an innocent | ||||||||||
not (depending on the information contained in the | misrepresentation; | ||||||||||
supplement) be notified that they are required to confirm | ‧ (if the application is made by an agent on your | ||||||||||
their applications. If applicant(s) have been so notified | behalf) warrant that you have validly and irrevocably | ||||||||||
but have not confirmed their applications in accordance | conferred on your agent all necessary power and | ||||||||||
with the | procedure to | be notified, all unconfirmed | authority to make this application; |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
‧ (if you are an agent for another person) warrant that | ‧ agree that the processing of your application, | |||||||||||||||||
reasonable enquiries have been made of the beneficial | including the despatch of refund cheque(s) (if any), | |||||||||||||||||
owner that this application is the only application | may be done by any of the receiving banks and is not | |||||||||||||||||
which will be made for the benefit of that other | restricted to the bank at which your Application Form | |||||||||||||||||
person on a BLUE Application Form and that you are | is lodged; | |||||||||||||||||
duly authorised to sign this Application Form as that | ||||||||||||||||||
‧ confirm that you are aware of the restrictions on the | ||||||||||||||||||
other person's agent; | Preferential Offering of the Reserved Shares described | |||||||||||||||||
‧ agree that | once | your application | is | accepted, your | ||||||||||||||
in the Prospectus; | 版 | |||||||||||||||||
application | will | be evidenced | by | the | results | of the | ||||||||||||
‧ understand that these declarations and representations | ||||||||||||||||||
Preferential Offering made available by the Company; | ||||||||||||||||||
will be relied upon by the Company and the Joint | ||||||||||||||||||
‧ warrant the truth and accuracy of the information | ||||||||||||||||||
Representatives in deciding whether or not to allocate | ||||||||||||||||||
contained in this application; | ||||||||||||||||||
any Reserved Shares in response to your application; | ||||||||||||||||||
‧ agree to disclose to the | Company, the H | Share | ||||||||||||||||
Registrar, the receiving banks, the Relevant Persons | ‧ if the laws of any place outside Hong Kong are | |||||||||||||||||
applicable to your application, you agree and warrant | ||||||||||||||||||
and the Orange and Blue Form eIPO Service | ||||||||||||||||||
樣 | ||||||||||||||||||
Provider any personal data about you or, with the | that you have complied with all such laws and | |||||||||||||||||
exception of HKSCC Nominees, the person(s) for | none of the Company nor the Relevant Persons will | |||||||||||||||||
whose benefit you have made the application which | infringe any laws outside Hong Kong as a result of | |||||||||||||||||
they require; | the acceptance of your offer to purchase any Reserved | |||||||||||||||||
‧ warrant that, in making an application, you or any | Shares, or any actions arising from your rights and | |||||||||||||||||
person(s) on whose behalf you may be acting is/are | obligations under the terms and conditions contained | |||||||||||||||||
Sample | ||||||||||||||||||
Qualifying Fosun Pharma H Shareholder(s); | in the Prospectus; | |||||||||||||||||
‧ represent, warrant and undertake that in making | ‧ agr | with the Company and for the benefit of each | ||||||||||||||||
this application, | you and/or, with | the exception of | Shar holder (and | so | that | the Company | shall be | |||||||||||
HKSCC Nominees, any person(s) for whose b ha f | d m d by their acceptance in whole or in part of this | |||||||||||||||||
you may be acting are not connected person(s) or | application to have agreed, for itself and on behalf of | |||||||||||||||||
person(s) who will become connected person(s) of the | ach Shar holder) (and if applicable, with each CCASS | |||||||||||||||||
Company immediately upon completion of the G obal | Participant giving | electronic | application instructions), | |||||||||||||||
Offering, the subscription for Reserved Shares by you | and the Company agree with each Shareholder, to | |||||||||||||||||
and/or, with the exception of HKSCC Nominees, any | observe and comply with the Companies Ordinance | |||||||||||||||||
person(s) on whose behalf you may be acting is not | (Chapter 622 of the Laws of Hong Kong), the | |||||||||||||||||
financed directly or indirectly by a connected | erson | Companies (Winding Up and Miscellaneous Provisions) | ||||||||||||||||
of the Company, and you and/or, with the exce tion | ||||||||||||||||||
of HKSCC No inees, any person(s) on whose behalf | Ordinance (Chapter 32 of the Laws of Hong Kong) and | |||||||||||||||||
you may be acting is not taking instructions from | the Articles of Association of the Company; | |||||||||||||||||
a connected person of the Co | pany in | aking this | ‧ agree with the Company and each Shareholder that | |||||||||||||||
subscription for Reserved Sh res; | the Shares are freely transferable by the Shareholder; | |||||||||||||||||
‧ agree th t your | pplic tion, any acceptance of it | and | ||||||||||||||||
and the resulting contr ct will be governed by and | ‧ understand that | the | Company | and | the | Relevant | ||||||||||||
construed in ccord nce with the laws of Hong Kong; | Persons are | entitled | to rely | on | any | warranty, | ||||||||||||
‧ undert ke | nd | gree to | ccept the Reserved Shares | |||||||||||||||
representation | or | declaration made | by | you in this | ||||||||||||||
applied for, | or | ny lesser | number | allocated | to you | |||||||||||||
application. In the event of the application being made | ||||||||||||||||||
under the application; | ||||||||||||||||||
by joint applicants, all the warranties, representations, | ||||||||||||||||||
‧ authorise the Company to place your name(s) on | ||||||||||||||||||
declarations and obligations | expressed | to | be | made, | ||||||||||||||
the Company's H hare register of members as the | ||||||||||||||||||
given | or assumed by or | imposed | on | the | joint | |||||||||||||
holder(s) of any Reserved Shares allocated to you and | ||||||||||||||||||
applicants shall be deemed to have been made, given | ||||||||||||||||||
such other registers as required under the Company's | ||||||||||||||||||
and assumed by and imposed on the applicants jointly | ||||||||||||||||||
Articles of | Association, | and | despatch | any | Share | |||||||||||||
and severally. You may be prosecuted if you make a | ||||||||||||||||||
certificate(s) (where applicable) and/or any refund | ||||||||||||||||||
false declaration. | ||||||||||||||||||
cheque(s) (where applicable) to you or (in case of | ||||||||||||||||||
joint applicants) the first-named applicant in this | You must complete this application in English, | |||||||||||||||||
Application Form by ordinary post at your own risk | unless otherwise stated, and you or (in case of joint | |||||||||||||||||
to the address stated on this Application Form (except | applicants) each of the joint applicants must sign this | |||||||||||||||||
if you have applied for 1,000,000 Reserved Shares or | application in writing (and not by way of personal | |||||||||||||||||
more you may collect your refund cheque and Share | chop), otherwise the application is liable to be | |||||||||||||||||
certificates (where applicable) in person); | rejected. |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
E. Power of attorney | If you do not collect your refund cheque(s) and/or share | ||||||
If your application is made by a person, duly authorised | certificate(s) personally within the time period specified for | ||||||
under a valid power of attorney, the Company and the | collection, they will be despatched promptly to the address | ||||||
' | as specified on this Application Form by ordinary post at | ||||||
Joint Representatives, as the Company s agent, may | |||||||
accept it at their discretion and on any conditions they | your own risk. | ||||||
think fit, including requiring evidence of the attorney's | If you apply for less than 1,000,000 Reserved Shares, your | ||||||
authority. The Company and the Joint Representatives, as | refund cheque(s) and/or share certificate(s) will be sent to | ||||||
the Company's agents, will have full discretion to reject | the address in your Application Form on or before Tuesday, | ||||||
or accept any application, in full or in part without giving | 24 September 2019, by ordinary post and at your own risk. | ||||||
any reason. | 版 | ||||||
The Company will not issue temporary documents of title. | |||||||
F. Determination of Offer Price | Share certificates will only become valid at 8:00 a.m. on | ||||||
The Offer Price is expected to be fixed on or around | Wednesday, 25 September 2019 provided that the Global | ||||||
Tuesday, 17 September 2019. Applicants are required | Offering has become unconditional in all respects and the | ||||||
to pay the Maximum Offer Price of HK$57.80 for | right of termination under the Underwriting Agreements | ||||||
each Offer Share (subject to refund) together with | and described in the section headed "Underwriting" in | ||||||
1% brokerage fee, 0.0027% | SFC transaction | levy | the Prospectus has not been exercised. No receipt will be | ||||
樣 | |||||||
and 0.005% Stock Exchange trading fee. If the Offer | issued for sums paid on application. In the event that the | ||||||
Price is not agreed among the Company and the Joint | Offer Price is less than the price per Reserved Share paid | ||||||
Representatives (on behalf of the Underwriters) on or | by you, the surplus application money (including the | ||||||
before Tuesday, 24 September 2019, the Global Offering | brokerage fee, the SFC transaction levy and the Stock | ||||||
will not proceed and will lapse. | Exchange trading fee attributable to such surplus) will | ||||||
Allotment of Reserved Shares | be refunded to you without interest. Investors who trade | ||||||
Subject to the terms and conditions as set out herein and in | Shares prior to the receipt of Share certificates or prior | ||||||
to the Share c rtificates becoming valid do so entirely at | |||||||
the Prospectus, the Reserved Shares will be allotted aft r the | |||||||
th ir own risk. | |||||||
application lists close. | |||||||
The Company expects to announce the Offer Price, the | v | Circumstanc s in which you will not be allotted Reserved | |||||
of indications of interest in the International Offering, the | Shar s | ||||||
level of applications under the Hong Kong Pub ic Off ring | You may not be allocated Reserved Shares for any of the | ||||||
and the Preferential Offering, and the basis of a ocation of | fo owing r asons: | ||||||
the Hong Kong Offer Shares and the Reserved Shares on | |||||||
1. If your application is revoked: | |||||||
Tuesday, 24 September 2019 in South China Morning Post | By completing and submitting an Application Form or | ||||||
(in English), Hong Kong Economic Times (in Chinese), | giving electronic application instructions | to HKSCC or | |||||
the website of the Stock Exchange at www.hkexnews.hk | |||||||
through the Blue Form eIPO service, | you agree that | ||||||
and the Company's website www.henlius.com. Results of | |||||||
your application or the application made by HKSCC | |||||||
allocations and the Hong Kong Identity Card/ ass ort/Hong | |||||||
Nominees on your behalf cannot be revoked on or before | |||||||
Kong business registration nu | bers of successful applicants | ||||||
the expiration of the fifth day after the time of the opening | |||||||
under the Hong Kong Public Offering and the Preferential | |||||||
of the application lists (excluding for this purpose any day | |||||||
Offering will be available on the above websites. | |||||||
which is not a business day), unless a person responsible | |||||||
If your | pplic tion for Reserved Shares is successful (in | for the Prospectus under Section 40 of the Companies | |||||
whole or in p rt) | (Winding Up and Miscellaneous Provisions) Ordinance | ||||||
If you apply for 1,000,000 or | ore Reserved Shares and have | (Chapter 32 of the Laws of Hong Kong) gives a public | |||||
provided | ll inform tion required by this Application Form, you | notice under that section which excludes or limits the | |||||
may collect your refund cheque(s) | nd/or share certificate(s) | responsibility of that person for the Prospectus. This | |||||
from Computersh re Hong Kong Investor Services Limited, at | agreement will take effect as a collateral contract with | ||||||
hops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's | the Company, and will become binding when you lodge | ||||||
Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. | this Application Form. This collateral contract will be | ||||||
on Tuesday, 24 eptember 2019 or such other place or date as | in consideration of the Company agreeing that they will | ||||||
notified by us in the newspapers. | not offer any Reserved Shares to any person on or before | ||||||
If you are an individual who is eligible for personal collection, | Tuesday, 24 September 2019, except by means of one of | ||||||
Samplethe procedures referred to in the Prospectus. | |||||||
you must not authorise any other person to collect for you. If | If your application has been accepted, it cannot be | ||||||
you are a corporate applicant which is eligible for personal | revoked. For this purpose, acceptance of applications | ||||||
collection, your authorised representative must provide a letter | |||||||
of authorisation from your corporation stamped with your | which are not rejected will be constituted by notification | ||||||
corporation's chop. | in the announcement of the results of allocation, and | ||||||
Both individuals and authorised representatives must | where such basis of allocation is subject to certain | ||||||
produce, at the time of collection, evidence of identity | conditions or provides for allocation by ballot, such | ||||||
acceptable to Computershare Hong Kong Investor Services | acceptance will be subject to the satisfaction of such | ||||||
Limited. | conditions or results of the ballot, respectively. |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
2. Full discretion of the Company, the Joint | ‧ the Company believe that by accepting the application, | ||||||
Representatives, and their respective agents or | the Company would violate the applicable securities or | ||||||
nominees, to reject or accept your application: | other laws, rules or regulations of the jurisdiction where | ||||||
The Company and the Joint Representatives or its or | this Application Form is received or where the applicant is | ||||||
their respective agents or nominees, have full discretion | resident; or | ||||||
to reject or accept any application, or to accept only part | ‧ the Company and the Joint Representatives, and | ||||||
of any application. No reasons have to be given for any | their respective agents or nominees, exercise their | ||||||
rejection or acceptance. | discretion to reject or accept any application, or to | ||||||
版 | |||||||
3. If the allotment of Reserved Shares is void: | accept only part of any application. No reasons have | ||||||
The allotment of Reserved Shares to you will be void if | to be given for any rejection or acceptance. | ||||||
the Listing Committee does not grant permission to list | 5. If you are applying by using the BLUE Application Form | ||||||
the Shares either: | for Assured Entitlement, you may apply for a number of | ||||||
‧ within three weeks from the closing of the application | Reserved Shares pursuant to your Assured Entitlement that | ||||||
lists; or | is equal to or less than the number stated in Box B. If you | ||||||
‧ within a longer period of up to six weeks if the Listing | intend to apply for a number of Reserved Shares that is | ||||||
Committee of the Stock Exchange notifies the Company | |||||||
less than your Assured Entitlement, you MUST apply for a | |||||||
of that longer period within three weeks of the closing | |||||||
number which is one of the numbers set out in the table in | |||||||
date of the application lists. | |||||||
the BLUE Application Form and make a payment of the | |||||||
4. You will not receive any allotment if: | |||||||
corresponding amount (other than HKSCC Nominees). | |||||||
‧ this Application Form is not completed in accordance | |||||||
with the instructions as stated herein; | You need to complete and sign the BLUE Application | ||||||
‧ this Application Form has not been duly signed (only | Form for Assured Entitlement and submit one cheque (or | ||||||
Sampledishonoured on its first presentation; | |||||||
written signatures are acceptable) (or in the case of a | banker's cashier order) for the exact amount of remittance | ||||||
joint application, not all applicants have signed); | print d in Box B or the corresponding amount payable | ||||||
‧ in respect of applicants who are corporate entiti s, this | as s t out in the table in the BLUE Application Form. If | ||||||
Application Form has not been duly signed (on y writt n | you int nd to apply for a number of Assured Entitlement | ||||||
signature is acceptable) by an authorised offic r or | which is not one of the numbers set out in the table in | ||||||
affixed with a company chop; | the BLUE Application Form for Assured Entitlement, | ||||||
‧ the | cheque/banker's cashier order/this App ication | you MUST apply by using Blue Form eIPO only. If you | |||||
Form is defective; | 樣 | ||||||
‧ this Application Form is not accom anied with a | wish to apply for excess Reserved Shares in addition to | ||||||
your Assured Entitlement, you should complete and sign | |||||||
cheque/banker's cashier order or is accom anied by | the BLUE Application Form for excess Reserved Shares | ||||||
more than one cheque/banker's cashier order for each | and lodge it, together with a separate remittance for | ||||||
of the application for Assured Entitlement and excess | the full amount payable on application in respect of the | ||||||
application for Reserved Shares; | excess Reserved Shares applied for or apply for through | ||||||
‧ the account na | e on cheque/banker's cashier order is | the Blue Form eIPO service via www.eipo.com.hk. | |||||
not pre-printed or certified by the issuing bank; | |||||||
‧ the cheque/banker's cashier order is not drawn on a | 6. If you are applying by using the BLUE Application | ||||||
Hong Kong doll r b nk | ccount in Hong Kong; | Form for excess Reserved Shares, you MUST apply for | |||||
‧ the n me of | the p yee indicated on the cheque/ | a number which is one of the numbers set out in the table | |||||
b nker's c shier order is not "BANK OF CHINA | in the BLUE Application Form for excess Reserved | ||||||
(HONG KONG) NOMINEES LIMITED - | Shares and make a payment of the corresponding | ||||||
HENLIUS BIOTECH PREFERENTIAL | amount (other than HKSCC Nominees). You need to | ||||||
OFFER"; | complete and sign the BLUE Application Form for | ||||||
‧ the cheque h s not been crossed "Account payee | excess Reserved Shares and submit a separate cheque | ||||||
only"; | (or banker's cashier order) for the exact amount of | ||||||
‧ the cheque was post-dated; | remittance. If you intend to apply for a number of excess | ||||||
‧ the | applicant's payment is not made correctly or | ||||||
Reserved Shares which is not one of the numbers set out | |||||||
the | applicant | pays by | cheque or | banker's | cashier | ||
in the table in the BLUE Application Form for excess | |||||||
order and the | cheque | or banker's | cashier | order is | |||
Reserved Shares, you MUST apply by using Blue Form | |||||||
‧ the applicant's name/the first applicant's name on | eIPO only. | ||||||
the joint application is not the same as the name pre- 7. If you intend to apply for both Reserved Shares pursuant | |||||||
printed or certified/endorsed by a person authorised | to your Assured Entitlement and excess Reserved Shares, | ||||||
' | you must submit both the BLUE Application Form for | ||||||
by the drawee bank on the cheque/banker s cashier | |||||||
order; | Assured Entitlement and the BLUE Application Form for | ||||||
‧ alteration(s) to the application details on this | excess Reserved Shares. Each BLUE Application Form | ||||||
Application Form has not been authorised by the | must be accompanied by a separate cheque (or banker's | ||||||
signature(s) of the applicant(s); | cashier order) for the exact amount of remittance. |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
Refund of your money | or otherwise render their services. It may also prevent | ||||||||||||||
If you do not receive any Reserved Shares or if your | or delay registration or transfer of the Reserved Shares | ||||||||||||||
application is accepted only in part, the Company will | which you have successfully applied for and/or the | ||||||||||||||
refund to you your application monies (including the | despatch of Share certificate(s), and/or the despatch of | ||||||||||||||
related 1% brokerage fee, 0.0027% SFC transaction levy | refund cheque(s) to which you are entitled. | ||||||||||||||
and 0.005% Stock Exchange trading fee) or the appropriate | It is important that holders of securities inform the | ||||||||||||||
portion thereof without interest. If the Offer Price is less | |||||||||||||||
Company and the H Share Registrar immediately of any | |||||||||||||||
than the Maximum Offer Price, the Company will refund to | inaccuracies in the personal data supplied. | ||||||||||||||
you the surplus application monies (including the related 1% | 2. | Purposes | |||||||||||||
brokerage fee, 0.0027% SFC transaction levy and 0.005% | |||||||||||||||
The personal data of the applicants and the holders of | |||||||||||||||
Stock | Exchange | trading fee) | without | interest. The | refund | ||||||||||
securities may be used, held and/or stored (by whatever | |||||||||||||||
procedures | are | stated in | the | "H. Despatch/Collection of | |||||||||||
means) for the following purposes: | |||||||||||||||
Share | Certificates/e-Refund | Payment | Institutions/Refund | ||||||||||||
‧ processing | of | your application and | refund cheque, | ||||||||||||
Cheques" in the "How to Apply for Hong Kong Offer | |||||||||||||||
where applicable, and verification of compliance with | |||||||||||||||
Shares and Reserved Shares" section of the Prospectus. | |||||||||||||||
the terms and application procedures set out in this | |||||||||||||||
Effect of the Information You Give to Computershare | Application Form and the Prospectus and announcing | ||||||||||||||
Hong Kong Investor Services Limited | results of allocations of the Reserved Shares; | ||||||||||||||
Computershare Hong Kong Investor Services Limited and | ‧ enabling compliance with all applicable laws and | ||||||||||||||
its related bodies' corporate, directors, officers, employees | regulations in Hong Kong and elsewhere; | of | |||||||||||||
and agents | ("Representatives") | expressly disclaim and | ‧ registering | new issues | or transfers | into or out | |||||||||
the name of | holders | of securities including, where | |||||||||||||
exclude to the maximum extent permitted by law any | |||||||||||||||
版 | |||||||||||||||
liability for any loss or damage suffered or incurred by the | applicable, in the name of HKSCC Nominees; | ||||||||||||||
‧ maintaining | or updating | the registers of holders | of | ||||||||||||
applicant or any other person or entity however caus d | |||||||||||||||
s curiti s of the Company; | |||||||||||||||
relating in any way to, or connected with, any information | |||||||||||||||
‧ conducting | or assisting | in the conduct | of signature | ||||||||||||
provided by or on behalf of the applicant on or in conn ction | |||||||||||||||
v rifications, | any other | verification | or | exchange | of | ||||||||||
with this document or any services provided hereund r, or | |||||||||||||||
information; | |||||||||||||||
any other written or oral communication provided by or on | |||||||||||||||
‧ stablishing | benefit | entitlements | of | holders | of | ||||||||||
behalf | of the applicant in | connection | with this docum nt | ||||||||||||
樣 | |||||||||||||||
or any services provided hereunder. This inc udes, without | s curiti s of the Company, such as dividends, rights | ||||||||||||||
issues and bonus issues, etc.; | |||||||||||||||
limitation, any errors or omissions in such information | |||||||||||||||
‧ distributing communications from the Company and | |||||||||||||||
however caused, or the Representatives or any other | erson | its subsidiaries; | |||||||||||||
or entity placing any reliance on such information or any | |||||||||||||||
‧ compiling statistical information and profiles of | |||||||||||||||
documentation, image, recording or re roduction of such | holders of securities; | ||||||||||||||
information, or its accuracy, co | leteness, currency or | ‧ making disclosures as required by laws, rules or | |||||||||||||
reliability. | regulations (whether statutory or otherwise) in Hong | ||||||||||||||
Personal Data | Kong or elsewhere; | ||||||||||||||
‧ disclosing relevant information to facilitate claims on | |||||||||||||||
Personal inform tion collection st | te | ent | |||||||||||||
entitlements; and | |||||||||||||||
The main | provisions of | the Personal Data (Privacy) | |||||||||||||
‧ any other incidental or | associated purposes relating | ||||||||||||||
Ordinance (Ch pter 486 of the L ws of Hong Kong) (the | |||||||||||||||
to the above and/or to enable the Company and the | |||||||||||||||
"Ordinance") c me into effect in Hong Kong on December | |||||||||||||||
H Share Registrar to | discharge their obligations | to | |||||||||||||
20, 1996. This Person l Inform tion Collection Statement | |||||||||||||||
holders of | securities | and/or regulators | and/or other | ||||||||||||
informs the | pplic nt for | nd holder of the Hong Kong | |||||||||||||
purpose to which the holders of securities may from | |||||||||||||||
Offer | hares of the policies and practices of the Company | ||||||||||||||
time to time agree. | |||||||||||||||
and its H hare Registrar in relation to personal data and the | |||||||||||||||
3. | Transfer of personal data | ||||||||||||||
Ordinance. | |||||||||||||||
Personal data held by the Company and the H Share | |||||||||||||||
1. Reasons for the collection of your personal data | |||||||||||||||
Registrar relating to the | applicants and | the holders | of | ||||||||||||
From time to time it | is | necessary for applicants for | securities will be kept confidential but the Company | ||||||||||||
Sample | |||||||||||||||
securities or registered holders of securities to supply | and the H Share Registrar, to the extent necessary for | ||||||||||||||
their latest correct personal data to the Company and | achieving the above purposes or any of them, may make | ||||||||||||||
its H Share Registrar when applying for securities or | such enquiries as they consider necessary to confirm the | ||||||||||||||
transferring securities into or out of their names or in | accuracy of the personal data and in particular, they may | ||||||||||||||
procuring the services of the H Share Registrar. Failure to | disclose, obtain or transfer (whether within or outside | ||||||||||||||
supply the requested data may result in your application | Hong Kong) the personal data of the applicants and the | ||||||||||||||
for securities being rejected or in delay or inability of | holders of securities to, from or with any and all of the | ||||||||||||||
the Company or its H Share Registrar to effect transfers | following persons and entities: |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
‧ the | Company or their respective appointed agents | in Box B in the Application Form. If you intend to apply | ||||
such as financial advisors and receiving bankers; | for a number of Reserved Shares that is less than your | |||||
‧ HKSCC and HKSCC Nominees, who will use the | Assured Entitlement, you MUST apply for a number | |||||
personal data for the purposes of operating CCASS | which is one of the numbers set out in the table in the | |||||
(in cases where the applicants have requested for the | BLUE Application Form for Assured Entitlement, you | |||||
Reserved Shares to be deposited into CCASS); | should (i) write the number of Reserved Shares applied | |||||
‧ any agents, contractors or third-party service providers who | for and the amount payable (as set out in the table in the | |||||
offer administrative, telecommunications, computer, | Application Form); (ii) complete and sign the Application | |||||
payment or other services to the Company and/or the | Form; and (iii) submit one cheque (or banker's cashier | |||||
H Share Registrar in connection with the operation of | order) for the same amount that you have written in the | |||||
their respective businesses; | Application Form (other than HKSCC Nominees). If | |||||
‧ the Stock Exchange, the SFC and any other statutory, | you intend to apply for a number of Assured Entitlement | |||||
regulatory or governmental bodies in Hong Kong or | which is not one of the numbers set out in the table in the | |||||
elsewhere; and | BLUE Application Form for Assured Entitlement, you | |||||
‧ any other | persons or institutions with which the | MUST apply by using Blue Form eIPO only. If you wish | ||||
holders of securities have or propose to have dealings, | to apply for excess Reserved Shares in addition to your | |||||
such as their bankers, solicitors, accountants or | Assured Entitlement, you should complete and sign the | |||||
stockbrokers. | BLUE Application Form for excess Reserved Shares and | |||||
4. Retention of personal data | lodge it, together with a separate remittance for the full | |||||
amount payable on application in respect of the excess | ||||||
The Company and its H Share Registrar will keep the | ||||||
Reserved Shares applied for版or apply for through the Blue | ||||||
personal data of the applicants and holders of securities | ||||||
Sample | ||||||
for as long as necessary to fulfil the purposes for which | Form eIPO service via www.eipo.com.hk. If you intend | |||||
the | personal data | were collected. Personal data which | to apply for a number of Reserved Shares that is equal to | |||
is no longer required will be destroyed or dea t with in | your Assur d Entitlement, you should (i) complete and | |||||
accordance with the Ordinance. | sign the Application Form and (ii) submit one cheque (or | |||||
5. Access to and correction of personal data | bank r's cashier order) for the exact amount of remittance | |||||
print d in Box B in the Application Form. | ||||||
The Ordinance provides the applicants and the ho d rs of | If you樣are applying by using the BLUE Application | |||||
securities with rights to ascertain whether the Com any | Form for excess Reserved Shares, you should (i) write | |||||
or | the | H Share Registrar holds their | ersonal data, to | the number of excess Reserved Shares applied for and the | ||
obtain a copy of that data, and to correct any data that | amount payable (as set out in the table on the Application | |||||
is inaccurate. In accordance with the Ordinance, the | Form); (ii) complete and sign the Application Form; and | |||||
Company and the H Share Registrar have the right | (iii) submit one separate cheque (or banker's cashier | |||||
to charge a reasonable fee for the processing of any | order) for the same amount that you have written on the | |||||
data access request. All requests for access to data or | Application Form. The number of excess Reserved Shares | |||||
correction of data or for infor | ation regarding policies | that you intend to apply for MUST be one of the numbers | ||||
and pr ctices | nd kinds of d ta held should be addressed | set out in the table in the Application Form for excess | ||||
to | the | Comp ny, | t its registered address disclosed | Reserved Shares (other than HKSCC Nominees). If you | ||
in | the | section | he ded "Corpor te Infor | ation" in the | intend to apply for a number of excess Reserved Shares | |
Prospectus or | s notified from time to time in accordance | which is not one of the numbers set out in the table in the | ||||
with | pplic ble l w, for the | ttention | of | the company | BLUE Application Form for excess Reserved Shares, you | |
secret ry, or the H | h re Registr r for the attention of the | MUST apply by using Blue Form eIPO only. | ||||
privacy compliance officer. | 2. Complete the form and sign it. Only written signatures | |||||
By signing this Application Form, you agree to all of the | will be accepted. | |||||
3. Staple your cheque or bank's cashier order to the form. | ||||||
above. | ||||||
You must pay for the application for Assured Entitlement | ||||||
How to make your application | ||||||
by one cheque or by one banker's cashier order and/ | ||||||
Instead of using the BLUE Application Form, you may | or pay for the application for excess Reserved Shares | |||||
apply for Reserved Shares through the Blue Form eIPO | ||||||
by one cheque or by one banker's cashier order. Each | ||||||
service at www.eipo.com.hkand make payment using | application must be accompanied by either a separate | |||||
PPS or the internet banking payment methods. | cheque or banker's cashier order. | |||||
1. If you are applying by using the BLUE Application | If you pay by cheque, the cheque must: | |||||
Form for Assured Entitlement, you may apply for a | ‧ be in Hong Kong dollars; | |||||
number of Reserved Shares pursuant to your Assured | ‧ be drawn on your Hong Kong dollar bank account in | |||||
Entitlement that is equal to or less than the number stated | Hong Kong; |
BLUE FORM
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk
‧ show your account name. This name must either be | CMB Wing Lung Bank Limited | ||
preprinted on the cheque, or be endorsed at the back | District | Branch Name | Address |
by a person authorised by the bank. This account | |||
name must be the same name as the name on this | Hong Kong Island | Head Office | 45 Des Voeux Road Central |
form. If it is a joint application, the account name | Kennedy Town Branch | 28 Catchick Street | |
must be the same as the name of the first-named | |||
applicant; | Kowloon | Mongkok Branch | B/F CMB Wing Lung Bank Centre, |
‧ be made payable to "BANK OF CHINA (HONG | 636 Nathan Road | ||
KONG) NOMINEES LIMITED - HENLIUS | |||
Tsim Sha Tsui Branch | 4 Carnarvon Road | ||
BIOTECH PREFERENTIAL OFFER"; | |||
‧ be crossed "Account Payee Only"; and | New Territories | Tsuen Wan Branch | 251 Sha Tsui Road |
‧ not be post-dated. | 5. This Application Form can be lodged at these times: |
Your application may be rejected if your cheque: |
‧ does not meet all these requirements; or | Thursday, 12 | September 2019 | - | 9:00 a.m. to 5:00 p.m. |
‧ is dishonoured on its first presentation. | Friday, 13 | September 2019 | - | 9:00 a.m. to 5:00 p.m. |
If you pay by banker's cashier order, the cashier | ||||
order must: | Monday, 16 | September 2019 | - | 9:00 a.m. to 5:00 p.m. |
‧ be in Hong Kong dollars; | Tuesday, 17 | September 2019 | - | 9:00 a.m. to 12:00 noon |
‧ be issued by licensed banks in Hong Kong, and have | 6. The latest time for lodging your application is 12:00 noon | |||
your name certified at the back of the order by a | ||||
on Tuesday, 17 September 2019 or, if the application lists | ||||
person authorised by the bank. The name on the back | ||||
Sample | ||||
of the order and the name on this Application Form | are not open on that day,版then by 12:00 noon on the next | |||
must be the same. If it is a joint application, the name | day the lists are open. The application lists will be open | |||
at the back of the order must be the same as the name | b tw | n 11:45 a.m. and 12:00 noon on that day, subject | ||
of the first-named applicant; | on y to w ather conditions. The application lists will not | |||
‧ be made payable to "BANK OF CHINA (HONG | op n if th re is: | |||
KONG) NOMINEES LIMITED - HENLIUS | ‧ a typhoon warning signal 8 or above; | |||
BIOTECH PREFERENTIAL OFFER"; | ‧ an | xtr me condition caused by a super typhoon | ||
‧ be crossed "Account Payee Only"; and | 樣 | |||
‧ not be post-dated. | announced by the Government of the Hong Kong | |||
Special Administrative Region; or | ||||
Your application is liable to be rejected if your cheque | ‧ a "black" rainstorm warning | |||
or banker's cashier order does not meet all these | in force in Hong Kong at any time between 9:00 a.m. | |||
requirements. | and 12:00 noon on Tuesday, 17 September 2019. Instead | |||
4. Fold this Application Form once and lodge it to one of | they will be open between 11:45 a.m. and 12:00 noon on | |||
the collection boxes at any of the following branches of | the next business day which does not have either of those | |||
Bank of China (Hong Kong) Li | ited and CMB Wing | warnings and/or extreme condition in force at any time | ||
Lung B nk Li | ited: | |||
between 9:00 a.m. and 12:00 noon. Business day means | ||||
Bank of China (Hong Kong) Li | ited | a day that is not a Saturday, Sunday or public holiday in | ||
District | Br nch N e | Address | Hong Kong. | |
Hong Kong Isl nd | Des Voeux Ro d | 111-119 Des Voeux Road West, | 7. The right is reserved to present all or any remittances | |
West Br nch | Hong Kong | for payment. However, your cheque or banker's | ||
Chai Wan Branch | Block B, Walton Estate, 341-343 | cashier order will not be presented for payment | ||
Chai Wan Road, Chai Wan, Hong | before 12:00 noon on Tuesday, 17 September 2019. | |||
Kong | You will not be given a receipt for your payment. | |||
Kowloon | Telford Plaza Branch | Shop Unit P2-P7, Telford Plaza, | ||
The Company will retain any interest accrued on | ||||
No.33 Wai Yip Street, Kowloon | your application monies. The right is also reserved | |||
Bay, Kowloon | ||||
to retain any Share certificate(s) and/or any surplus | ||||
Olympian City Branch | Shop 133, 1/F, Olympian City 2, 18 | |||
application money(ies) or refunds pending clearance | ||||
Hoi Ting Road, Kowloon | ||||
of your cheque or banker's cashier order. | ||||
New Territories | Metro City Branch | Shop 209, Level 2, Metro City | ||
Phase 1, Tseung Kwan O, New | ||||
Territories | ||||
Ma On Shan Plaza Branch | Shop 2103, Level 2, Ma On Shan | |||
Plaza, Sai Sha Road, Ma On Shan, | ||||
New Territories |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
Shanghai Henlius Biotech, Inc.
上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司
(於中華人民共和國註冊成立的股份有限公司)
全 球 發 售 | ||||||
申請條件 | 不管招股章程或本申請表格的任何其他 | |||||
除另有指明外,此等條件所用詞彙具備招股章程 | 條文或藍表eIPO 服務的條款及條件,倘 | |||||
所賦予的相同涵義。 | 本公司全權酌情信納有關交易獲豁免或 | |||||
甲. 申請人資格 | 毋須遵守導致上述限制的法例或規例, | |||||
1. | 閣下(申請人)及 閣下為其利益而提出 | |||||
則本公司保留權利允許任何復星醫藥H | ||||||
申請的任何人士必須為合資格復星醫藥 | 樣 | |||||
H 股股東並年滿18 歲。 | 股股東接納其預留股份的保證配額。 | |||||
2. | 如 閣下屬商號,則須以個別成員的名 | 5. | 聯名申請人的總數不可超過四人。 | |||
義而非以商號的名義作出申請。 | 乙. | 分配預留股份 | ||||
3. | 如 閣下屬法人團體,申請表格必須加 | 倘有效申請之預留股份數目少於或相等 | ||||
版 | ||||||
蓋公司印鑑(附有公司名稱)並由獲正式 | 於 | 閣下之保證配額,在受本申請表格所 | ||||
授權的高級職員簽署,並須註明其代表 | 載條款及條件的規限下,且假設優先發售 | |||||
身份。 | 之條件已達成,則申請將會獲全數接納。 | |||||
4. | 除上市規則及聯交所發出的指引信許可 | 倘申請的預留股份數目少於 閣下的保證配 | ||||
的情況或聯交所已授予的任何相關豁免 | 額, 閣下必須申請本申請表格內數目及款 | |||||
批准外,倘若 閣下或(香港結算代理人 | ||||||
項一覽表所列的其中一個數目並支付相應款 | ||||||
除外) 閣下為其利益而提出申請的任何 | ||||||
額(香港結算代理人除外)。倘 閣下擬申請 | ||||||
人士為下列人士,則不得申請認購任何 | ||||||
並非藍色申請表格申請保證配額表中載列的 | ||||||
預留股份: | ||||||
其中一個保證配額數目, 閣下必須用藍表 | ||||||
‧ 本公司及╱或任何附屬公司之股份 | ||||||
eIPO 申請。倘 | 閣下擬申請保證配額以外的 | |||||
的現有實益擁有人; | ||||||
超額預留股份,則須填妥並簽署申請超額預 | ||||||
‧ 本公司及╱或本公司任何附屬公司 | ||||||
留股份之藍色申請表格,並單獨匯款足額支 | ||||||
之董事或最高行政人員; | ||||||
‧ 上述任何人士的聯繫人; | 付所申請超額預留股份的應付股款,或透過 | |||||
‧ 本公司的關連人士或於緊隨全球發 | www.eipo.com.hk使用藍表eIPO 服務遞交 | |||||
售完成後將成為本公司關連人士的 | 申請。倘申請的預留股份數目多於 閣下的 | |||||
人士;或 | 保證配額,相關保證配額的申請將獲全數接 | |||||
‧ 不合資格復星醫藥H 股股東。 | 納,但超額預留股份的申請則只在有足夠的 | |||||
不合資格復星醫藥H 股股東指於記錄日 | ||||||
可用預留股份的情況下方獲接納。倘預留股 | ||||||
期登記地址位於香港以外司法權區或據 | ||||||
份的超額申請: | ||||||
復星醫藥另行得悉為香港以外司法權區 | ||||||
(i) | 少於可用預留股份,則可用預留股份將 | |||||
居民的復星醫藥H 股股東,復星醫藥及 | ||||||
Sample本公司董事根據彼等就該等股東所作出 | 首先悉數分配以滿足該等預留股份的超 | |||||
的查詢,考慮到有關復星醫藥H 股股東 | 額申請,而其後將由聯席代表酌情分配 | |||||
所處有關司法權區法律的限制或該司法 | 至國際發售; | |||||
權區有關監管機構或證券交易所的規定 | (ii) 與可用預留股份相同,則可用預留股份 | |||||
後,認為將彼等排除在優先發售之外屬 | 將悉數分配以滿足該等預留股份的超額 | |||||
必要或合宜者。 | 申請;或 |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
- 多於可用預留股份,則可用預留股份將 人)代表委託 閣下作為代理人或代名人的 按與香港公開發售超額認購情況下常用 每名人士:
的分配基準一致的分配基準分配,當中 | ‧ | 指示及授權本公司及╱或聯席代表(或 | ||
認購額較細的申請將獲較高的分配百分 | 彼等各自的代理或代名人),根據本公 | |||
比。倘滿足超額申請後有任何剩餘的股 | 司章程細則的規定,代表 閣下簽立任 | |||
份,有關股份將由聯席代表酌情重新分 | 何過戶表格、成交單據或其他文件,並 | |||
配至國際發售。為補足股份的零碎持有 | 代表 | 閣下辦理其他一切必需手續,以 | ||
量至一手完整持有量而作出的任何超額 | 完成以 閣下名義登記 閣下獲分配的 | |||
申請將不會獲得優先處理。 | 任何預留股份,或以其他方式令招股章 | |||
除上述者外,優先發售將不受國際發售與香 | 程及本申請表格所述的各項安排落實生 | |||
港公開發售之間的回補安排所限。未附帶正 | 效; | |||
確金額申請款項的任何申請將視為完全無效 | ‧ | 承諾簽署所有文件及辦理所有必需手 | ||
續,以便可按本公司章程細則的規定, | ||||
且不會向有關申請人配發任何預留股份。 | ||||
讓 | 閣下登記成為 | 閣下獲分配的預留 | ||
除透過藍表eIPO 服務(www.eipo.com.hk) 或 | ||||
股份的持有人; | ||||
藍色申請表格申請預留股份外,合資格復星 | ||||
‧ | 聲明、保證及承諾 | 閣下明白預留股份 | ||
醫藥H 股股東亦可使用白色或黃色申請表格 | ||||
並無亦不會根據《美國證券法》進行登 | ||||
或透過中央結算系統向香港結算發出電子認 | ||||
版 | ||||
購指示或透過白表eIPO 服務作出一份香港 | 記,而(香港結算代理人除外) 閣下 | |||
Sample | 或 | 閣下作為其代表或為其利益購買預 | ||
發售股份申請。 | 留股份的任何其他人士身處美國境外(定 | |||
合資格復星醫藥H 股股東根據香港公開發售 | 義見S 規例)及S 規例第902 條第(h)(3) 段 | |||
使用白色或黃色申請表格或向香港結算發出 | 所述的人士; | |||
電子認購指示或透過白表eIPO 服務申請香 | ‧樣確認 閣下提出本申請時僅依賴招股章 | |||
港發售股份,在配額或分配方面並無優先 | 程所載的資料及陳述,而除招股章程任 | |||
權。 | 何補充文件所載者外,將不會依賴任何 | |||
合資格復星醫藥H 股股東可按其各自於記錄 | 其他資料或陳述; | |||
日期每持有132 股復星醫藥H 股股份的完整 | ‧ | 同意本公司、有關人士或橙表及藍表 | ||
倍數獲發保證配額一個預留股份的基準提出 | eIPO 服務供應商現時及日後均毋須對並 | |||
申請。於記錄日期持有少於132 股復星醫藥 | 非載於招股章程(及其任何補充文件)的 | |||
H 股的合資格復星醫藥H 股股東將不會享有 | 任何資料及陳述負責; | |||
預留股份的保證配額,但仍有權透過申請超 | ||||
‧ | 同意(在不損害 閣下可能擁有的任何其 | |||
額預留股份參與優先發售。 | ||||
他權利的情況下)本申請一經接納,即不 | ||||
丙. 補充資料 | ||||
得因無意的失實陳述而撤銷; | ||||
倘刊發招股章程的任何補充文件,已提交 | ||||
‧ (如 申 請 由 代 理 代 表 閣 下 提 出 )保 | ||||
申請的申請人可能會或可能不會(視乎補充 | 證 | 閣下已向 閣下的代理有效及不可 | ||
文件所載資料而定)獲通知彼等須確認其申 | 撤回地授予一切必需的權力及授權以提 | |||
請。如申請人已獲通知但未有根據獲通知的 | 出本申請; | |||
程序確認彼等的申請,則所有未經確認申請 | ‧ (如 | 閣下為他人的代理)保證已向實益 | ||
將會無效。受上文所規限,申請一經提交即 | 擁有人作出合理查詢,證實本申請乃為 | |||
不得撤銷,而申請人將視為根據已按經補充 | 該人士利益以藍色申請表格而作出的唯 | |||
的招股章程提出申請。 | 一申請,而 閣下已獲正式授權,以該 | |||
丁. 填交本申請表格的效用 | 人士代理的身份簽署本申請表格; | |||
本申請表格一經填妥及提交,即表明 閣下 | ‧ | 同意 | 閣下的申請一經接納, 閣下的申 | |
(及如屬聯名申請人,即 閣下與聯名申請 | 請將以本公司公佈的優先發售結果為證 | |||
人共同及個別)本身或(如作為代理人或代名 | 明; |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
‧ 保證本申請所載資料屬真實及準確; | ‧ | 確認 閣下知悉招股章程所述有關預留 | ||
‧ 同意向本公司、H 股證券登記處、收款 | 股份的優先發售限制; | |||
銀行、有關人士及橙表及藍表eIPO 服務 | ‧ | 明白本公司及聯席代表將依賴此等聲明 | ||
供應商披露彼等所需關於 閣下或(香港 | 及陳述,以決定是否就 閣下提出的申 | |||
結算代理人除外) 閣下為其利益提出申 | 請向 閣下分配任何預留股份; | |||
請的人士的任何個人資料; | ‧ 倘香港境外任何地方的法律適用於 閣 | |||
版 | ||||
‧ 保證在提出申請時, 閣下或 | 閣下可能 | 下的申請,則 | 閣下同意並保證, 閣下 | |
代其行事之任何人士為合資格復星醫藥 | 已遵守所有該等法律,而本公司或有關 | |||
H 股股東; | 人士概不會因接納 | 閣下購買任何預留 | ||
‧ 聲 明、 保 證 及 承 諾, 在 提 出 本 申 請 | 股份的要約,或因 | 閣下在招股章程所 | ||
時, 閣下及╱或(香港結算代理人除 | 載條款及條件項下的權利與責任所產生 | |||
外) 閣下可能代其行事之任何人士並非 | 的任何行動而觸犯香港境外任何法律; | |||
樣 | ||||
關連人士,亦並非將在緊隨全球發售完成 | ‧ | 向本公司(並為各股東的利益)表示同意 | ||
後成為本公司關連人士的人士,而 閣下 | (及從而使本公司(為其本身並代表各股 | |||
及╱或(香港結算代理人除外) 閣下可 | 東)藉其接納全部或部分本申請而視為已 | |||
能代其行事之任何人士認購預留股份並非 | 同意)(及(如適用)向發出電子認購指示 | |||
直接或間接由本公司的關連人士提供資 | 的各中央結算系統參與者表示同意),以 | |||
Sample | 及本公司向各股東表示同意,遵守及符 | |||
金,且 閣下及╱或(香港結算代理人除 | 合香港法例第622 章公司條例、香港法 | |||
外) 閣下可能代其行事之任何人士並非 | 例第32 章公司(清盤及雜項條文)條例及 | |||
根據本公司關連人士的指示作出預留股份 | 本公司章程細則; | |||
的是次認購; | ‧ 向本公司及各股東表示同意股份可由該 | |||
‧ 同意 閣下的申請、接納申請及由此而 | 股東自由轉讓;及 | |||
產生的合約均受香港法例管轄,並按其 | ‧ | 明白本公司及有關人士均有權依賴 閣 | ||
詮釋; | 下於本申請作出的任何保證、陳述或聲 | |||
‧ 承諾並同意接納所申請的預留股份, | 明。倘為聯名申請人提出的申請,表示 | |||
或 閣下根據申請所獲分配的任何較少 | 由聯名申請人提出、作出或承擔或須履 | |||
數目; | 行的所有保證、陳述、聲明及責任,均 | |||
‧ 授權本公司將 閣下的姓名╱名稱列 | 視為由各申請人共同及個別地提出、作 | |||
入H 股股份登記冊,作為 閣下獲分配 | ||||
出及承擔及須履行。 | 閣下如作出虛假 | |||
的任何預留股份的持有人,及根據本公 | ||||
聲明可被檢控。 | ||||
司章程細則規定的本公司股東名冊內, | ||||
除另有註明外, 閣下必須以英文填妥本申 | ||||
並按本申請表格上所示地址以普通郵遞 | ||||
請,而 閣下或(倘為聯名申請人)各聯名申 | ||||
方式寄發任何股票(如適用)及╱或任何 | ||||
請人必須親筆簽署本申請(不得以個人印章 | ||||
退款支票(如適用予 閣下或(如為聯名 | ||||
代替),否則申請可被拒絕受理。 | ||||
申請人)本申請表格內排名首位的申請 | ||||
戊. 授權書 | ||||
人,郵誤風險概由 閣下自行承擔(除非 | ||||
倘 | 閣下的申請由根據授權書獲正式授權的 | |||
如 閣下申請1,000,000 股或以上預留股 | ||||
人士提出,本公司及聯席代表(作為本公司的 | ||||
份,則可親自領取 閣下的退款支票及 | ||||
代理)可酌情按彼等認為合適的任何條件(包 | ||||
股票(如適用)); | ||||
括出示代表的授權證明文件)接納申請。本 | ||||
‧ 同意任何收款銀行,而不限於 | 閣下遞 | |||
公司及聯席代表(作為本公司的代理)將可全 | ||||
交申請表格的銀行,可處理 | 閣下的申 | |||
權酌情決定拒絕或接納任何申請的全部或部 | ||||
請,包括寄發退款支票(如有); 分,而毋須提供任何理由。
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
己. 釐定發售價 | 寄往 | 閣下申請表格所示地址,郵誤風險由 閣 | ||
預期發售價於二零一九年九月十七日(星期二)或 | 下承擔。 | |||
前後釐定。申請人須繳付每股發售股份57.80 港 | 本公司不會發出臨時所有權文件。 | |||
元(多繳款項可予退還)的最高發售價,另加1% | 股票僅會於全球發售在所有方面成為無條件及招 | |||
經紀佣金、0.0027% 證監會交易徵費及0.005% 聯 | 股章程「包銷」一節所述的包銷協議終止權利並無 | |||
交所交易費。倘若本公司與聯席代表(代表包銷 | 行使的情況下,方會於二零一九年九月二十五日 | |||
商)並無於二零一九年九月二十四日(星期二)或 | 份: | 版 | ||
(星期三)上午八時正成為有效的所有權憑證。 | ||||
之前協定發售價,全球發售將不會進行並將告失 | 已繳付的申請款項將不獲發收據。倘發售價低 | |||
效。 | 於 | 閣下支付的每股預留股份價格,多繳的申請 | ||
預留股份的配發 | 款項(包括多繳款項應佔的經紀佣金、證監會交 | |||
在本申請表格及招股章程載列的條款及條件規限 | 易徵費及聯交所交易費)將不計利息退還予 閣 | |||
下,預留股份將於截止辦理申請登記後配發。 | 下。投資者在收到股票前或在股票成為有效前買 | |||
樣 | ||||
本公司預期於二零一九年九月二十四日(星期二) 賣股份,須自行承擔全部風險。 | ||||
在《南華早報》(英文)、《香港經濟日報》(中文)、 | 閣下不獲配發預留股份的情況 | |||
聯交所網站(www.hkexnews.hk) 及本公司網站 | 閣下可能基於下列任何理由而不獲分配預留股 | |||
(www.henlius.com) 公佈發售價、國際發售的踴 | ||||
躍程度、香港公開發售及優先發售的認購水平以 | 1. 倘 | 閣下的申請被撤回: | ||
及香港發售股份及預留股份的分配基準。香港公 | ||||
開發售及優先發售的分配結果及成功申請人的香 | 填妥及遞交申請表格或向香港結算或利用藍表 | |||
IPO 服務發出電子認購指示後,即表示 閣下 | ||||
港身份證╱護照╱香港商業登記號碼亦同於上述 | ||||
網站公佈。 | 同意不得於開始辦理申請登記後第五日(就此而 | |||
言,不包括任何非營業日)屆滿或之前撤回申請 | ||||
倘 | 閣下成功申請認購(全部或部分)預留股份 | |||
或香港結算代理人代表 閣下提出的申請,除非 | ||||
如 | 閣下申請認購1,000,000 股或以上預留股 | |||
根據香港法例第32 章公司(清盤及雜項條文)條 | ||||
份,且已提供本申請表格所規定全部資料, 閣 | ||||
例第40 條對招股章程負責的人士根據該條發出公 | ||||
下可於二零一九年九月二十四日(星期二)或本公 | ||||
告,免除或限制該人士對招股章程的責任。此協 | ||||
司在報章上公佈的其他地點或日期的上午九時正 | ||||
議將成為本公司訂立的附屬合約,並在 閣下遞 | ||||
至下午一時正,親身前往香港中央證券登記有限 | ||||
交本申請表格時即具約束力。該附屬合約的代價 | ||||
公司(地址為香港灣仔皇后大道東183 號合和中 | ||||
為本公司同意,除按招股章程所述任何一項程序 | ||||
心17 樓1712-1716 室)領取 閣下的退款支票及 | ||||
外,不會於二零一九年九月二十四日(星期二)或 | ||||
╱或股票。 | ||||
之前向任何人士提呈發售任何預留股份。 | ||||
如 | 閣下為個人申請人並合資格親身領取, 閣 | |||
閣下的申請一經接納,則不得撤回。就此而言, | ||||
下不得授權任何其他人士代領。如 閣下為公司 | ||||
在公告公佈分配結果即屬接納未遭拒絕的申請, | ||||
申請人並合資格親身領取, 閣下的授權代表須 | ||||
而倘有關分配基準受若干條件規限或訂定以抽籤 | ||||
攜同蓋上公司印鑑的授權書領取。 | ||||
個人申請人及授權代表領取時均須出示香港中央 | 方式分配,則申請獲接納與否將分別視乎能否達 | |||
證券登記有限公司接納的身份證明文件。 | 成有關條件或抽籤的結果而定。 | |||
如 | 閣下並無在指定領取時間內親身領取退款支 | 2. 本公司、聯席代表以及彼等各自的代理或代 | ||
名人可全權酌情決定拒絕或接納 閣下的申 | ||||
票及Sample╱或股票,有關退款支票及╱或股票將會立 | ||||
刻以普通郵遞方式寄往本申請表格所示地址,郵 | 請: | |||
誤風險由 閣下承擔。 | 本公司及聯席代表或彼等各自的代理或代名 | |||
如 | 閣 下 申 請 認 購1,000,000 股 以 下 預 留 股 | 人可全權酌情決定拒絕或接納任何申請,或 | ||
份, 閣下的退款支票及╱或股票將於二零一九 | 僅接納任何部份申請,而毋須就任何拒絕或 | |||
年九月二十四日(星期二)或之前以普通郵遞方式 | 接納提供任何理由。 |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
3. | 倘預留股份配發作廢: | ‧ 本公司及聯席代表及其各自的代理或代 | ||
倘上市委員會在下列期間未批准股份上市, | 名人行使酌情權,決定拒絕或接納任何 | |||
則配發予 閣下的預留股份將告作廢: | 申請,或僅接納部分申請。拒絕或接納 | |||
‧ 由截止辦理申請登記日期起計三星期 | 申請毋須給予任何理由。 | |||
內;或 | 5. 倘 閣下使用藍色申請表格申請保證配 | |||
‧ (倘聯交所上市委員會在截止辦理申請登 | 額, 閣下可申請相等於或少於乙欄所列數目 | |||
記日期後三星期內通知本公司延長有關 | 的保證配額的預留股份。倘 閣下擬申請少 | |||
期間)由截止辦理申請登記日期起計最多 | 於 閣下保證配額的預留股份, 閣下必須申 | |||
六星期內。 | 請藍色申請表格一覽表所列數目之一,並相 | |||
4. | 在下列情況下, 閣下將不獲任何配發: | 應付款(香港結算代理人除外)。 | ||
‧ 本申請表格並無按照本申請表格所載指 | 閣下須就保證配額填妥並簽署藍色申請表 | |||
示填妥; | 格,並提交一張支票(或銀行本票),金額須 | |||
‧ 本申請表格並無妥為簽署(僅接受親筆簽 | 樣 | |||
為乙欄所印列的確切金額或藍色申請表格一 | ||||
名)(倘為聯名申請,則未經全部申請人 | 覽表所載的相應應付金額。倘 閣下擬申請 | |||
簽署); | 並非藍色申請表格申請保證配額表中載列的 | |||
‧ 就法人團體申請人而言,本申請表格未 | 其中一個保證配額數目, 閣下必須使用藍表 | |||
經獲授權的高級職員妥為簽署(僅接受親 | 版 | |||
筆簽名)或未加蓋公司印鑑; | eIPO 申請。倘 閣下擬申請保證配額以外的 | |||
超額預留股份,則須填妥並簽署申請超額預 | ||||
Sample | ||||
‧ 支票╱銀行本票╱本申請表格有缺陷; | 留股份之藍色申請表格,並單獨匯款足額支 | |||
‧ 本申請表格並無就各份保證配額的申請 | 付所申請超額預留股份的應付股款,或透過 | |||
及預留股份的超額申請附有支票╱銀行 | www. ipo.com.hk使用藍表eIPO 服務遞交申 | |||
本票或附有超過一張支票╱銀行本票; | 請。 | |||
‧ 支票╱銀行本票並無預印賬戶名稱或賬 | 6. | 倘 閣下使用藍色申請表格申請超額預留股 | ||
戶名稱未經開具銀行證明; | 份, 閣下必須申請藍色申請表格一覽表所 | |||
‧ 支票╱銀行本票並非自香港的港元銀行 | 列超額預留股份數目之一,並相應付款(香 | |||
賬戶開出; | 港結算代理人除外)。 閣下須就超額預留 | |||
‧ 支票╱銀行本票的抬頭人並非「中國銀行 | 股份填妥並簽署藍色申請表格,並提交一張 | |||
( 香港) 代理人有限公司-復宏漢霖生物 | 獨立開出的支票(或銀行本票)支付確切金 | |||
技術優先發售」; | 額。倘 閣下擬申請並非藍色申請表格申請 | |||
‧ 支票並無劃線註明「只准存入抬頭人賬 | ||||
超額預留股份表中載列的其中一個保證配額 | ||||
戶」; | ||||
數目, 閣下必須使用藍表eIPO 申請。 | ||||
‧ 支票為期票; | ||||
7. | 倘 閣下擬同時申請保證配額的預留股份及 | |||
‧ 申請人未正確付款或申請人以支票或銀 | ||||
行本票付款但支票或銀行本票於首次過 | 超額預留股份, 閣下必須同時提交保證配 | |||
額的藍色申請表格及超額預留股份的藍色申 | ||||
戶時不獲兌現; | ||||
請表格。每份藍色申請表格必須附上一張獨 | ||||
‧ 申請人名稱╱聯名申請的排名首位申請 | ||||
立開出的支票(或銀行本票)支付確切金額。 | ||||
人名稱並非預印名稱或並非由銀行授權 | ||||
退回款項 | ||||
人士在支票或銀行本票背書的名稱相 | ||||
若 | 閣下未獲分配任何預留股份或申請僅部分獲 | |||
同; | ||||
接納,本公司將不計利息退回 閣下的申請股款 | ||||
‧ 本申請表格所提供申請資料的更改未獲 | ||||
申請人簽署授權; | (包括相關的1% 經紀佣金、0.0027% 證監會交易 | |||
‧ 本公司相信如接納申請,會違反收取本 | 徵費及0.005% 聯交所交易費)或其中適當部分。 | |||
申請表格或申請人地址所在司法權區的 | 如發售價低於最高發售價,本公司將不計利息 | |||
適用證券或其他法例、規則或規例;或 | 退回多收申請股款(包括相關的1% 經紀佣金、 |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
0.0027% 證監會交易徵費及0.005% 聯交所交易 | 2. | 目的 | |||
費)。有關退款程序載於招股章程「如何申請香港 | 證券申請人及持有人的個人資料可以作以下 | ||||
發售股份及預留股份」一節「H. 發送╱領取股票╱ | 目的使用、持有及╱或保存(以任何方式): | ||||
電子退款指示╱退款支票」。 | ‧ 處理 | 閣下的申請及退款支票(如適用) | |||
閣下提供給香港中央證券登記有限公司的資訊的 | 及核實是否符合本申請表格及招股章程 | ||||
載列的條款和申請程序,以及公佈預留 | |||||
有關影響 | |||||
版 | |||||
香港中央證券登記有限公司和其有關連的法人團 | 股份的分配結果; | ||||
‧ 遵守香港及其他地區的一切適用法律及 | |||||
體、董事、高級人員、僱員及代理人(「代表」)在 | |||||
法規; | |||||
法律所容許的最大限度內明確卸棄及免除在任何 | |||||
‧ 登記新發行證券或以證券持有人的名義 | |||||
方面與申請人或代表申請人在此文件提供的或與 | |||||
(包括以香港結算代理人名義(如適用)) | |||||
此文件或在此文件下提供的任何服務相關的任何 | |||||
轉讓或受讓證券; | |||||
性。 | |||||
樣 | |||||
資料,或任何申請人或代表申請人提供與此文件 | ‧ 存置或更新本公司證券持有人的名冊; | ||||
或在此文件下提供的任何服務相關的任何其它書 | ‧ 核實或協助核實簽名、任何其他核證或 | ||||
面或口頭通訊,有關或相關由申請人或任何其他 | 交換信息; | ||||
人士或實體所遭受或招致不論如何造成的任何損 | ‧ 確立本公司證券持有人的受益權利,如 | ||||
失或損害的任何法律責任。此包括,但不限於, | 股息、供股和紅股等; | ||||
Sample | |||||
該等資料中不論如何造成的任何錯誤或遺漏,或 | ‧ | 分發本公司及其附屬公司的通訊; | |||
代表或任何其他人士或實體對該等資料或任何該 | ‧ 編製統計信息和證券持有人資料; | ||||
等資料的文件記錄、影像、記錄或複製品作出的 | ‧ 根據香港或其他地區的法律、規則或規 | ||||
任何依據,或其準確性、完整性、合時性或可靠 | 例進行披露(無論法定或其他規定); | ||||
‧ 披露有關信息以便就權益提出申索;及 | |||||
個人資料 | ‧ 與上述有關的任何其他附帶或相關目的 | ||||
及╱或使本公司及H 股證券登記處能履 | |||||
個人資料收集聲明 | |||||
行對證券持有人及╱或監管機構承擔的 | |||||
香港法例第486 章《個人資料(私隱)條例》(「條 | |||||
責任及╱或證券持有人不時同意的任何 | |||||
例」)的主要條款已於一九九六年十二月二十日在 | |||||
其他目的。 | |||||
香港生效。此項個人資料收集聲明是向香港發售 | |||||
3. | 轉交個人資料 | ||||
股份申請人和持有人說明有關本公司及其H 股證 | |||||
券登記處在個人資料和條例方面的政策和慣例。 | 本公司及H 股證券登記處持有關於證券申請 | ||||
人及持有人的個人資料將會保密,但本公司 | |||||
1. 收集 閣下個人資料的原因 | |||||
及H 股證券登記處可以在達到上述目的或當 | |||||
證券申請人或證券登記持有人以自己的名義 | |||||
中任何目的的必要的情況下,作出彼等認為 | |||||
申請認購證券或轉讓或受讓證券時或尋求H | |||||
必要的查詢以確認個人資料的準確性,尤其 | |||||
股證券登記處的服務時,須不時向本公司及 | |||||
彼等可向或從下列任何及全部人士和實體或 | |||||
其H 股證券登記處提供其最近的準確個人資 | |||||
與下列任何及全部人士和實體互相披露、取 | |||||
料。未能提供所要求的資料可能導致 閣下 | |||||
得或轉移(無論在香港境內或境外)證券申請 | |||||
申請證券被拒或延遲,或本公司或其H 股證 | |||||
人及持有人的個人資料: | |||||
券登記處無法落實轉讓或提供服務,亦可能 | |||||
‧ 本公司或彼等各自指定的代理,如財務 | |||||
妨礙或延遲登記或轉讓 閣下成功申請認購 | |||||
顧問和收款銀行; | |||||
的預留股份及╱或發送股票及╱或發送 閣 | |||||
‧ 香港結算及香港結算代理人,彼等將會 | |||||
下應得的退款支票。 | |||||
就中央結算系統的運作使用個人資料(倘 | |||||
如提供的個人資料有任何錯誤,證券持有人 | 申請人要求將預留股份記存於中央結算 | ||||
須立即通知本公司和H 股證券登記處。 | 系統); |
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
‧ 任何向本公司及╱或H 股證券登記處提 | 外)。倘 閣下擬申請並非藍色申請表格申 | ||
供與其各自業務營運有關的行政、電 | 請保證配額表中載列的其中一個保證配額數 | ||
訊、電腦、付款或其他服務的代理、承 | 目, 閣下必須使用藍表eIPO 申請。倘 閣 | ||
包商或第三方服務供應商; | 下擬申請保證配額以外的超額預留股份,則 | ||
‧ 聯交所、證監會及香港或其他地區的任 | 須填妥並簽署申請超額預留股份之藍色申請 | ||
何其他法定、監管或政府機關;及 | 表格,並單獨匯款足額支付所申請超額預留 | ||
‧ 證券持有人與其進行或擬進行交易的任 | 股份的應付股款,或透過www.eipo.com.hk | ||
何其他人士或機構,如彼等的銀行、律 | 使用藍表eIPO 服務遞交申請。倘 閣下擬 | ||
師、會計師或股票經紀等。 | 申請相等於 閣下保證配額的預留股份數 | ||
4. | 保留個人資料 | 目, 閣下應:(i) 填妥並簽署申請表格;及 | |
本公司及H 股證券登記處將按收集個人資料 | (ii) 提交一張支票(或銀行本票),金額須為申 | ||
所需的用途保留證券申請人及持有人的個人 | 請表格乙欄所印列確切金額。 | ||
資料。無需保留的個人資料將會根據條例銷 | 倘 | 閣下使用藍色申請表格申請超額預留 | |
毀或處理。 | 股份, 閣下應:(i) 填寫所申請的超額預留 | ||
5. | 查閱和更正個人資料 | 股份數目及應付金額(申請表格一覽表所載 | |
條例規定,證券申請人及持有人有權確定 | 者);(ii) 填妥並簽署申請表格;及(iii) 提交 | ||
本公司或H 股證券登記處是否持有其個人資 | 一張獨立開出的支票(或銀行本票),金額須版 | ||
料,並有權索取有關該資料的副本並更正任 | 為 | 閣下在申請表格填寫的相同金額。 閣 | |
何不準確資料。根據條例,本公司和H 股證 | 下擬申請的超額預留股份數目必須為申請表 | ||
券登記處有權就處理任何查閱資料的要求收 | 格申請超額預留股份一覽表所載數目之一 | ||
取合理的費用。所有查閱資料或更正資料的 | (香港結算代理人除外)。倘 閣下擬申請並 | ||
非藍色申請表格申請超額預留股份表中載列 | |||
要求或查詢有關政策及慣例以及持有資料種 | |||
樣 | |||
類的要求,均須按招股章程「公司資料」一節 | 的其中一個保證配額數目, 閣下必須使用 | ||
藍表eIPO 申請。 | |||
所披露或不時按適用法例獲知會的註冊地址 | |||
請填妥並簽署申請表格。僅接納親筆簽名。 | |||
送交本公司公司秘書或送交H 股證券登記處 2. | |||
私隱監察人員。 | 3. | 支票或銀行本票須緊釘於表格。 閣下必須 | |
以一張支票或一張銀行本票支付保證配額的 | |||
如 | 閣下簽署本申請表格,即表示 | 閣下同意上 | |
申請款項及╱或以一張支票或一張銀行本票 | |||
述各項。 | |||
支付超額預留股份的申請款項。每份申請均 | |||
申請程序 | |||
須附帶一張獨立支票或銀行本票。 | |||
除 使 用 藍 色 申 請 表 格 外, 閣 下 亦 可 透 過 | |||
如以支票繳付款項,該支票必須: | |||
www.eipo.com.hk利用藍表eIPO 服務申請預留 | |||
‧ 為港元支票; | |||
股份並使用繳費靈或網上銀行付款方法付款。 | |||
‧ 由香港的港元銀行賬戶開出; | |||
1. 倘 閣下使用藍色申請表格申請保證配 | |||
‧ 顯示 閣下的賬戶名稱,而該賬戶名必 | |||
額, 閣下可申請相等於或少於申請表格 | |||
須預印於支票,或由有關銀行授權人在 | |||
乙欄所列數目的保證配額的預留股份。 | |||
該支票背面簽署證明賬戶名。該賬戶名 | |||
倘 閣下擬申請少於 閣下保證配額的預 | |||
必須與 閣下於本表格上的姓名相同。 | |||
留股份, 閣下必須申請藍色申請表格申請 | |||
如屬聯名申請,則賬戶名稱必須與排名 | |||
保證配額表中載列的其中一個保證配額數 | |||
首位申請人的名稱相同; | |||
Sample | |||
目, 閣下應:(i) 填寫所申請的預留股份數 | ‧ 註明抬頭人為「中國銀行( 香港) 代理人 | ||
目及應付金額(申請表格一覽表所載者); | |||
有限公司-復宏漢霖生物技術優先發 | |||
(ii) 填寫並簽署申請表格;及(iii) 提交一張 | |||
售」; | |||
支票(或銀行本票),金額須為 | 閣下在申 | ||
‧ 劃線註明「只准存入抬頭人賬戶」;及 | |||
請表格填寫的相同金額(香港結算代理人除 ‧ 不得為期票。
藍表
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格
下列情況將導致申請可能不獲受理: | 5. | 閣下可於下列時間遞交本申請表格: | ||||
‧ 支票不符合所有上述規定;或 | 二零一九年九月十二日(星期四) - 上午九時正至下午五時正 | |||||
‧ 支票首次過戶時不獲兌現。 | ||||||
二零一九年九月十三日(星期五) - 上午九時正至下午五時正 | ||||||
如以銀行本票繳付款項,該本票必須: | ||||||
二零一九年九月十六日(星期一) - 上午九時正至下午五時正 | ||||||
‧ 為港元; | ||||||
二零一九年九月十七日(星期二) - 上午九時正至中午十二時正 | ||||||
‧ 由香港持牌銀行發出,並由發出本票銀 | ||||||
行的授權人在本票背面簽署證明 閣下 | 6. | 遞交申請的截止時間是二零一九年九月十七 | ||||
版 | ||||||
姓名。本票背面所顯示姓名須與本申請 | 日(星期二)中午十二時正,如該日並無開 | |||||
表格所填寫的姓名相同。如屬聯名申 | 始登記認購申請,則為下一日開始登記認購 | |||||
請,本票背面所示姓名必須與排名首位 | 申請的中午十二時正。本公司將於當日上午 | |||||
申請人的姓名相同; | 十一時四十五分至中午十二時正期間登記認 | |||||
‧ 註明抬頭人為「中國銀行( 香港) 代理人 | 購申請,惟須視乎當日天氣情況而定。如下 | |||||
有限公司-復宏漢霖生物技術優先發 | 列警告信號在二零一九年九月十七日(星期 | |||||
售」; | ||||||
二)上午九時正至中午十二時正期間任何時 | ||||||
‧ 劃線註明「只准存入抬頭人賬戶」;及 | ||||||
間在香港懸掛,將不會登記申請: | ||||||
‧ 不得為期票。 | ||||||
‧ 八號或以上颱風警告信號; | ||||||
如 閣下的支票或銀行本票不符合上述所有 | ||||||
‧ 香港特別行政區政府公佈由超強颱風引 | ||||||
規定,則 | 閣下的申請可能遭拒絕受理。 | |||||
Sample | 起的極端環境;或 | |||||
4. 將本申請表格對摺一次,然後投入中國銀行 | ‧ 「黑色」暴雨警告信號。 | |||||
(香港)有限公司及招商永隆銀行有限公司的 | 如在該日的下一個營業日上午九時正至中午 | |||||
下列任何一間分行的收集箱: | 十二時正期間任何時間並無懸掛上述任何警 | |||||
中國銀行(香港)有限公司 | 樣 | |||||
地區 | 分行名稱 | 地址 | 告及╱或出現極端環境,申請認購登記將在 | |||
香港島 | 德輔道西分行 | 香港德輔道西111-119號 | 該下一個營業日上午十一時四十五分至中午 | |||
柴灣分行 | 香港柴灣道341-343 號宏德居 | 十二時正期間開始。營業日指星期六、星期 | ||||
B 座 | 日或香港公眾假期以外的日子。 | |||||
九龍 | 德福廣場分行 | 九龍灣偉業街33 號德福廣場 | 7. | 本公司保留將 閣下的一切或任何股款過戶 | ||
P2-P7號舖 | 的權利,然而, 閣下的支票或銀行本票不 | |||||
奧海城分行 | 九龍海庭道18 號奧海城二期 | 會於二零一九年九月十七日(星期二)中午 | ||||
一樓133 號 | 十二時正前過戶。 | 閣下不會就已繳付款項 | ||||
新界 | 新都城分行 | 新界將軍澳新都城一期二樓 | 獲發收據。本公司將保留 閣下的申請款項 | |||
209 號 | 的任何應得利息。在 閣下的支票或銀行本 | |||||
馬鞍山廣場分行 | 新界馬鞍山西沙路馬鞍山廣 | |||||
票過戶前,本公司亦有權保留任何股票及╱ | ||||||
場L2 層2103 號 | ||||||
或任何多收的申請款項或退款。 | ||||||
招商永隆銀行有限公司 | ||||||
地區 | 分行名稱 | 地址 | ||||
香港島 | 總行 | 德輔道中45 號 | ||||
堅尼地城分行 | 吉席街28 號 | |||||
九龍 | 旺角分行 | 彌敦道636 號招商永隆銀行中 | ||||
心地庫 | ||||||
尖沙咀分行 | 加拿分道4 號 | |||||
新界 | 荃灣分行 | 沙咀道251 號 |
Attachments
- Original document
- Permalink
Disclaimer
HKEx - Hong Kong Exchanges and Clearing Ltd. published this content on 12 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2019 22:56:06 UTC